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SCIENTIFIC OPINION 
Scientific Opinion on an application (EFSA-GMO-NL-2009-70) for the 
placing on the market of genetically modified drought tolerant maize 
MON 87460 for food and feed uses, import and processing under 
Regulation (EC) No 1829/2003 from Monsanto
1 
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2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Maize  MON 87460  was  developed  through  Agrobacterium-mediated  transformation  and  expresses  the  cold 
shock protein B (CspB) from Bacillus subtilis and neomycin phosphotransferase II (NPTII) from Escherichia 
coli to reduce yield loss under water-limited conditions. Maize MON 87460 contains a single copy of the cspB 
and nptII expression cassettes. Bioinformatic analysis of the flanking sequences and the open reading frames 
spanning  the  junctions  created  by  the  transformation  did  not  raise  safety  issues.  Comparative  analyses 
established that, besides the expression of the CspB and NPTII proteins, some differences were observed in the 
composition of forage and grain produced from maize MON 87460 compared with its conventional counterpart, 
when grown under well-watered conditions. Given the magnitude of these changes and the characteristics of 
these endpoints, the EFSA GMO Panel concluded that the observed differences do not raise safety concerns for 
humans and animals. Under stressful conditions, maize MON 87460 can show enhanced agronomic performance 
characteristics and some differences in chemical composition in comparison with its conventional counterpart. 
Given the intended trait, the observed differences were not unexpected, and did indicate no safety concerns. The 
safety assessment identified no concerns regarding the potential toxicity and allergenicity of the CspB and NPTII 
proteins, or of maize MON 87460. Maize MON 87460 is as nutritious as any other maize and can be used in the 
same way. In cases of spillage, there are no indications of increased likelihood of the establishment or survival of 
feral maize plants MON 87460. Risks associated with a theoretically possible horizontal gene transfer from 
maize MON 87460 to bacteria have been analysed in detail, including different scenarios of integration, and did 
not raise safety concerns for the intended uses of maize MON 87460. The post-market environmental monitoring 
plan and reporting intervals are in line with the intended uses of maize MON 87460. 
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SUMMARY 
Following the submission of an application (EFSA-GMO-NL-2009-70) under Regulation (EC) No 
1829/2003  from  Monsanto,  the  Panel  on  Genetically  Modified  Organisms  of  the  European  Food 
Safety Authority (EFSA GMO Panel) was asked to deliver a Scientific Opinion on the safety of the 
genetically modified (GM) drought tolerant maize MON 87460
4 for food and feed uses, import and 
processing of maize MON 87460 and all derived products but excluding cultivation in the European 
Union (EU). 
In delivering its Scientific Opinion, the EFSA GMO Panel considered: the application EFSA -GMO-
NL-2009-70; additional information supplied by the applicant; scientific comments submitted by the 
Member States; and relevant scientific publications.  
The EFSA GMO Panel evaluated maize MON  87460 with reference to the intended uses and 
principles described in its risk assessment and monitoring guidelines. The scientific evaluation of the 
risk assessment included molecular characterisation of the inserted DNA and expression of the target 
proteins. An evaluation of the comparative analysis of composition  and agronomic and phenotypic 
traits was undertaken, and the safety  of the newly expressed proteins and the whole food/feed were 
evaluated with respect to potential toxicity, allergenicity and nut ritional quality. An evaluation of 
environmental impacts and of the post-market environmental monitoring plan was undertaken. 
Maize MON 87460 was developed through Agrobacterium-mediated transformation and expresses the 
cold shock protein B (CspB) from Bacillus subtilis and neomycin phosphotransferase II (NPTII) from 
Tn5  of  Escherichia  coli.  Maize  MON 87460  was  developed  to  provide  reduced  yield  loss  under 
conditions in which water is limited compared with conventional maize. The CspB protein is an RNA 
chaperone  associated  with  enhanced  abiotic  stress  tolerance  in  bacteria  and  plants,  through  its 
interaction with RNA secondary structures, limiting their misfolding and allowing cells to maintain 
cellular functions under various stress conditions. In maize MON 87460, this genetic modification 
aims to reduce yield loss caused by drought stress. 
The molecular characterisation data establish that maize MON 87460 contains a single copy of the 
cspB  and  nptII  expression  cassettes,  and  lacks  other  sequences  from  the  transformation  vector. 
Bioinformatic analysis of the flanking sequences and the open reading frames spanning the junctions 
created  by  the  transformation  did  not  raise  safety  issues.  The  stability  of  the  inserted  DNA  was 
confirmed  over  multiple  generations.  The  levels  of  the  CspB  and  NPTII  protein  from  maize 
MON 87460 grown in field studies performed under different environmental conditions, including 
water-limited conditions, were assessed. 
The EFSA GMO Panel compared the composition and phenotypic and agronomic characteristics of 
maize MON 87460 with those of its conventional counterpart and assessed all statistically significant 
differences identified. The EFSA GMO Panel concludes that, besides the expression of the CspB and 
NPTII proteins, some differences were observed in the composition of forage and grain produced from 
maize  MON 87460,  compared  with  its  conventional  counterpart,  when  grown  under  well-watered 
conditions. Given the magnitude of these changes and the characteristics of these endpoints, the EFSA 
GMO Panel concludes that the observed differences do not  raise safety concerns for humans and 
animals. The EFSA GMO Panel notes that under water-limited and other stressful conditions, maize 
MON 87460  can  show  enhanced  agronomic  performance  characteristics  (e.g.  yield)  and  some 
differences  in  chemical  composition  in  comparison  with  its  conventional  counterpart.  Given  the 
intended trait, the observed differences were not unexpected, and did indicate no safety concerns. 
The safety assessment of the newly expressed protein and the whole crop included an analysis of data 
from analytical and bioinformatics studies, as well as in vitro pepsin and pancreatin resistance tests 
with  the  CspB  protein  and  a  subchronic  90-day  rat  feeding  study.  The  NPTII  protein  has  been 
evaluated previously and did not raise safety concerns. The EFSA GMO Panel concludes that maize 
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MON 87460  is  as  safe  as  its  conventional  counterpart;  there  is  no  evidence  that  the  genetic 
modification might significantly change the overall allergenicity of maize MON 87460. The results of 
the study on chickens for fattening concerning zootechnical performance support the conclusion that 
maize MON 87460 can be used as other maize sources as a feedingstuff in animal nutrition. The EFSA 
GMO  Panel  considers  that  maize  MON 87460  is  as  safe  and  as  nutritious  as  its  conventional 
counterpart and commercial varieties, and concluded that this maize and derived products are unlikely 
to have adverse effects on human and animal health, in the context of their intended uses. 
The application EFSA-GMO-NL-2009-70 covers the import and processing of maize MON 87460 for 
food and feed uses but excludes its cultivation in the EU. Therefore, there is no requirement for 
scientific information on the possible environmental effects associated with the cultivation of maize 
MON 87460. There are no indications of an increased likelihood of the establishment and spread of 
feral maize plants in cases of accidental release into the environment of viable grains from maize 
MON 87460 during transport and processing. Considering the intended uses of maize MON 87460 as 
food and feed, interactions with the biotic and abiotic environment are not considered to be an issue 
owing to the low levels of exposure. Risks associated with a theoretically possible horizontal transfer 
from maize MON 87460 nptII and cspB genes to bacteria have been analysed in detail, including 
different scenarios of integration, and did not raise safety concerns for the intended uses of maize 
MON 87460. The scope of the post-market environmental monitoring plan provided by the applicant 
is in line with the intended uses of maize MON 87460. Furthermore, the EFSA GMO Panel agrees 
with the reporting intervals proposed by the applicant in the general surveillance plan.  
In conclusion, the EFSA GMO Panel considers that the information available for maize MON 87460 
addresses scientific issues indicated by its risk assessment and monitoring guidelines and the scientific 
comments raised by the Member States, and that maize MON 87460, as described in this application, 
is as safe as its conventional counterpart and non-GM reference varieties with respect to potential 
effects on human and animal health and the environment, in the context of its intended uses. 
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BACKGROUND 
On  29  May  2009,  the  European  Food  Safety  Authority  (EFSA)  received  from  the  Competent 
Authority of the Netherlands an application (Reference EFSA-GMO-NL-2009-70), for authorisation 
of genetically modified (GM) drought tolerant maize MON 87460 (Unique Identifier MON-8746Ø-4), 
submitted by Monsanto within the framework of Regulation (EC) No 1829/2003 on GM food and 
feed.
5 After having received the application EFSA-GMO-NL-2009-70 and in accordance with Articles 
5(2)(b) and 17(2)(b) of Regulation (EC) No 1829/2003, EFSA  informed Member States and the 
European Commission, and made the summary of the application available to the public on the EFSA 
website. EFSA initiated a formal review of the application to check compliance with the requirements 
laid down in Articles 5(3)  and 17(3) of Regulation (EC) No 1829/2003. On 1  December 2009 and 
8 January 2010, EFSA received additional information requested under completeness check (requested 
on 9 July 2009 and 14 December 2009). On  28  January  2010, EFSA declared the application as 
formally valid in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003. 
EFSA made the valid application available to Member States and the European Commission, and 
consulted  nominated  risk  assessment  bodies  of  Member  States,  including  na tional  Competent 
Authorities within the meaning of Directive 2001/18/EC
6 following the requirements of Articles 6(4) 
and 18(4) of Regulation (EC) No 1829/2003, to request their scientific opinion. Member State bodies 
had three months after the date of receipt of the valid application (until 28 April 2010) within which to 
make their opinion known. 
The EFSA Scientific Panel on Genetically Modified Organisms (EFSA GMO Panel) carried out an 
evaluation of the scientific risk assessment of the maize MON  87460 for food and feed uses, import 
and processing, in accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003. When 
carrying out the safety evaluation, the EFSA GMO Panel took into account the principles described in 
its risk assessment and monitoring guidelines (EFSA, 2006a, 2011b), the scientific comments of the 
Member States and the additional information provided by the applicant and re levant scientific 
publications. 
The  EFSA  GMO  Panel  requested  from  the  applicant  additional  information  on  12  May 2010, 
20 December 2010,  and  8  July 2011.  The  applicant  provided  the  requested  information  on 
4 October 2010, 18 April 2011 and 30 April 2012, respectively. After receipt and asse ssment of the 
full data package, the EFSA GMO Panel finalised its risk assessment on maize MON 87460. 
In giving its  Scientific Opinion on maize MON 87460 to the European Commission, the Member 
States and the applicant, and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 
1829/2003, EFSA has endeavoured to respect a time limit of six months from the acknowledgement of 
the valid application. As additional information was requested by the EFSA GMO Panel, the time 
limit of six months was extended accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of 
Regulation (EC) No 1829/2003. 
According to Regulation (EC) No 1829/2003, this  Scientific Opinion  is to be seen as the report 
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall 
opinion in accordance with Articles 6(5) and 18(5). 
TERMS OF REFERENCE 
The EFSA GMO Panel was requested to carry out a scientific risk assessment of maize MON 87460 
for  food  and  feed  uses,  import  and  processing  in  accordance  with  Articles  6(6)  and  18(6)  of 
Regulation (EC) No 1829/2003. Where applicable, any conditions or restrictions which should be 
                                                       
5  Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed (OJ L 268, 18/10/2003, pp. 1–2). 
6  Directive 20010/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberat e release of 
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imposed on the placing on the market and/or specific conditions or restrictions for use and handling, 
including post-market monitoring requirements based on the outcome of the risk assessment and, in 
the case of GMOs or food/feed containing or consisting of GMOs, conditions for the protection of 
particular ecosystems/environment and/or geographical areas should be indicated in accordance with 
Articles 6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003.  
The EFSA GMO Panel was not requested to give a Scientific Opinion on information required under 
Annex II  to  the  Cartagena  Protocol,  nor  on  the  proposals  for  labelling  and  methods  of  detection 
(including sampling and the identification of the specific transformation event in the food/feed and/or 
food/feed produced from it), which are matters related to risk management. 
Being outside the remit of the Regulation (EC) 1829/2003, the EFSA GMO Panel did not conclude on 
the efficacy of the drought tolerance trait introduced in maize MON 87460 under stressed conditions. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
for food and feed uses, import and processing  
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ASSESSMENT 
1.  Introduction 
Maize  MON 87460  was  evaluated  with  reference  to  its  intended  uses  and  taking  account  of  the 
principles described in the risk assessment and monitoring guidelines of the EFSA Scientific Panel on 
Genetically Modified organisms (GMO Panel) (EFSA, 2006a,b, 2010b, 2011b). The evaluation of the 
risk assessment presented here is based on the information provided in the application relating to 
maize MON 87460 submitted in the European Union (EU), including additional information from the 
applicant, as well as issues raised by the Member States and relevant scientific publications. 
2.  Issues raised by Member States 
The scientific comments raised by the Member States are addressed in Annex G of the EFSA overall 
opinion
7 and have been considered in this Scientific Opinion. 
3.  Molecular characterisation 
Maize MON 87460 was developed through Agrobacterium-mediated transformation of conventional 
maize variety LH59 and expresses a cspB gene from Bacillus subtilis encoding a cold shock protein B 
(CspB)  and  the  nptII  gene  from  Escherichia  coli  encoding  the  neomycin  phosphotransferase II 
(NPTII) protein conferring resistance to kanamycin and related antibiotics. The latter was used as a 
marker to facilitate the selection process of transformed plant cells. The CspB protein is an RNA 
chaperone  associated  with  enhanced  abiotic  stress  tolerance  in  bacteria  and  plants,  through  its 
interaction with RNA secondary structures, limiting their misfolding and allowing cells to maintain 
cellular functions under various stress conditions (Phadtare et al., 2002a,b; Castiglioni et al., 2008). In 
maize MON 87460, this genetic modification aims  to reduce  yield loss caused by drought stress. 
Bacillus subtilis is a common soil bacterium, expressing a 67-amino acid CspB chaperone protein. 
Maize MON 87460 was genetically transformed to express an identical chaperone protein, with the 
exception of one amino acid change resulting from the DNA cloning procedure. The plant-expressed 
protein was named CspB-L2V, accordingly.  
3.1.  Evaluation of relevant scientific data 
3.1.1.  Transformation process and vector constructs 
Maize MON 87460 was obtained by Agrobacterium-mediated transformation of isolated immature 
embryos from the conventional maize LH59 variety, using the binary plasmid vector PV-ZMAP595 
and the Agrobacterium tumefaciens (also known as Rhizobium radiobacter) strain ABI.
8  
Two expression cassettes are located between the right and left borders of the transfer DNA (T-DNA), 
driving the expression of the cspB gene and nptII gene in plant tissues.
9 The cspB expression cassette 
contains the promoter, leader and first intron of the rice (Oryza sativa) actin 1 gene (act1), the cspB 
coding  sequence,  and  the  3   non-translated  sequence  of  the  transcript  7  gene  (T-tr7)  from 
A. tumefaciens. The cspB coding sequence is translated into the CspB-L2V protein, which differs from 
the  B. subtilis  CspB  protein  by  one  leucine-to-valine  substitution  at  amino  acid  position 2.  This 
sequence modification was intentionally introduced to facilitate the construction of the plasmid vector 
PV-ZMAP595 for plant transformation.  
The  nptII  expression  cassette  contains  the  nptII  coding  sequence  under  the  regulation  of  a  35S 
promoter  from  the  Cauliflower  mosaic  virus  (P35S)  and  the  3   non-translated  sequence  from  the 
A. tumefaciens nopaline synthase (T-nos) gene; the nptII expression cassette is flanked by two loxP 
sites, allowing its potential excision in the presence of the Cre recombinase from the corresponding 
                                                       
7  http://registerofquestions.efsa.europa.eu/  
8  Technical Dossier/Section C1. 
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Cre/lox site-specific recombination system of bacteriophage origin. However, the nptII cassette was 
not excised in maize MON 87460. In addition, bioinformatic analysis was conducted and indicated 
that, on a theoretical basis, double homologous recombination could occur owing to the presence of 
sequences from A. tumefaciens.
10 The impact of the  lox sequences and other bacterial sequences on 
plant to bacteria gene transfer is described in Section 6.1.1.2. 
Four genetic elements exist outside of the T-DNA borders that are essential for the maintenance and 
selection of the vector ZMAP595 in bacteria and that are not expected to be transferred into the maize 
genome: oriV, origin of replication for the maintenance of the plasmid in Agrobacterium; rop, coding 
sequence of repressor of primer protein for the maintenance of plasmid copy number in E. coli; ori, 
origin of replication from pBR322 for the maintenance of the plasmid in E. coli; and aadA, a bacterial 
promoter and coding sequence from transposon Tn7 that codes for a 3 -adenylyltransferase enzyme 
conferring spectinomycin and streptomycin resistances, used as selection marker in E. coli prior to 
plant transformation. 
3.1.2.  Transgene constructs in maize MON 87460 
Molecular analyses were performed to characterise the DNA integrated in maize MON 87460.
11 In 
order to determine the copy number of the T -DNA and the genetic elements it contained, Southern 
blot  analyses  were  performed  using :  (1)  DNA  extracted from  maize  MON 87640  and  from  a 
conventional maize with a similar genetic background; (2) three restriction enzyme combinations; and 
(3) sets of probes covering the entire plasmid PV-ZMAP595 (T-DNA and backbone sequences). The 
molecular characterisation showed that  maize MON 87640 contains a single insert, comprising both 
the cspB and nptII expression cassettes, and no backbone sequences derived from the vector outside 
the T-DNA could be detected in the maize genome as the result of transformation.
12  
Sequence analysis of overlapping polymerase chain reaction (PCR) fragments covering the full length 
of the T-DNA insert in maize MON 87460 indicated that the right border region is absent. In addition, 
733 base pairs (bp) of the rice actin  1 promoter are deleted, resulting in the removal of regulatory 
elements (McElroy et al., 1990; Wang et al., 1992) and leaving approximately 115 bp of the proximal 
part of the promoter.
13 The truncated rice actin 1 promoter in maize MON 87460 was designated as P-
Ract1
87460. The analysis demonstrated the integrity and expected  organisation of the other genetic 
elements of the T-DNA insert in maize MON 87460, compared with the T-DNA of the donor plasmid 
PV-ZMAP595. 
To  determine  the  DNA  sequence  at  the  pre-insertion  site,  PCR  amplification  was  performed  on 
parental (LH59) genomic DNA using primers designed from the 5  and 3  flanking sequences of the 
MON 87460 T-DNA insert. Sequence comparison between the pre-insertion site in the comparator 
(LH59) and the MON 87460 T-DNA flanking regions identified a 22 bp deletion at the integration 
site.  
To assess whether the insertion of the T-DNA in maize MON 87460 disrupted any endogenous genes 
of maize, 1121 bp of the 5  flanking region and 784 bp of the 3  flanking region were used to search 
nucleotide and protein sequence databases, using the BLASTN and BLASTX algorithms. There is no 
evidence that the insert in maize MON 87460 disrupts any known maize coding sequences.
14 The 
results also confirmed that the insert is located in the nuclear genome . This could also be deduced 
from the observed Mendelian segregation of the integrated DNA.  
In order to assess whether the insertion resulted in the creation of novel open reading frames (ORFs) at 
the junctions with the flanking DNA regions,  the DNA sequence spanning the 5  and 3  junctions of 
                                                       
10   Additional information October 2010. 
11   Technical Dossier/Section D2/Skipwith et al. (2007). 
12   Additional information October 2010 and Zong et al. (2010). 
13   Additional information October 2010. 
14   Technical Dossier/Section D2/Tu and Silvanovich (2009c)/Additional information October 2010. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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the maize MON 87460 insertion site was  analysed for the presence of all ORFs defined between 
translation termination codons in the six possible frames and originating or terminating within the 
maize MON 87460 insertion site.
15 Their putative translation products were used to search updated 
toxin and allergen databases by the FASTA algorithm. In addition, the presence of  eight-amino acid 
perfect matches between the known allergens of the database and the potential trans lation products 
from the ORFs was examined. No alignment met or exceeded the threshold for potential allergenicity 
(EFSA, 2010),  and no relevant similarities to known toxic proteins were shown, supporting the 
conclusion that the ORFs would not raise safety issues.  
3.1.3.  Information on the expression of the insert 
The scope of the application covers food and feed uses, import and processing of maize MON 87460. 
CspB and NPTII proteins were quantified using enzyme-linked immunosorbent assay (ELISA) for 
different developmental stages and tissue types from maize grown in the field in the USA (season 
2006) and Chile (season 2006–2007).
16 In the USA, plants were grown at six sites corresponding to a 
range of environmental conditions relevant to maize cultivation, and plants were grown under normal 
agronomic practices (i.e. with no water shortage).
17 Three field trial sites were in Chile and a strip-plot 
design was used to assess maize grown under two irrigation regimes (well   watered and water  
limited).
18 The water-limited plots were managed to impose drought stress by withholding irrigation 
from the late vegetative phase through to the early grain fill stage, to assess changes in CspB and 
NPTII protein levels under different soil moisture conditions.  
The CspB protein was expressed at a low level in all tissues relevant to the scope of this application , 
and the levels of the CspB protein tended to decline over the growing season. For grain the expression 
levels varied between 0.02 and 0.10 µg/g dry weight, and for forage between 0.04 and 0.22 µg/g dry 
weight (see Table 1). No obvious difference was observed in CspB protein levels in tissues collected 
from plants grown under well -watered or water-limited conditions for any of the analysed tissues 
(Table 1).  
Table 1: Ranges of CspB and NPTII levels in maize MON 87460 (µg/g dry weight)  
Protein  Plant 
part  USA 2006  Chile 2006–2007 
well watered 
Chile 2006–2007 
water limited 
CspB 
Grain  0.05–0.10  0.03–0.08  0.02–0.05 
Forage  0.04–0.17  0.08–0.14  0.07–0.22 
NPTII 
Grain  <LOQ  <LOQ  <LOQ 
Forage  0.05–0.20  0.13–0.19  0.12–0.22 
LOQ: limit of quantification. 
 
In the NPTII expression analysis, the protein was found to be expressed at a low level in forage, 
whereas the levels of the NPTII protein in grain tissue samples were below the NPTII assay limit of 
quantification (Table 1). 
3.1.4.  Inheritance and stability of inserted DNA 
The stability of the insert was demonstrated over seven backcrossed generations containing maize 
MON 87460  using  Southern  blot  analysis.
19  Segregation  analyses  demonstrated  the  expected 
inheritance and stability of the inserted sequences across multiple generations. The EFSA GMO Panel 
considers that, should instability leading to loss of the trait(s) occur, no safety issue would arise. 
                                                       
15   Technical Dossier/Section D2/Silvanovich and Tu (2009). 
16   Technical Dossier/Section D3. 
17   Mozaffar and Silvanovich (2008a). 
18   Shi et al. (2008a). 
19   Technical Dossier/Section D5. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
for food and feed uses, import and processing  
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3.2.  Conclusion 
The molecular characterisation data establish that the maize MON 87460 contains one copy of the 
cspB and nptII expression cassettes. No other parts of the plasmid used for transformation are present 
in the transformed plant. The expression of the genes introduced by genetic modification has been 
adequately analysed. The results of the bioinformatic analyses of the inserted DNA and the flanking 
regions did not raise safety issues. The stability of the inserted DNA was confirmed over several 
generations and a Mendelian inheritance pattern was demonstrated. The EFSA GMO Panel considers 
this to be an adequate analysis that does not raise safety issues. 
4.  Comparative analysis 
4.1.  Evaluation of relevant scientific data 
Table 2 provides an overview of the various studies that have been carried out for the comparative 
analysis of maize MON 87460 versus its conventional counterpart and non-GM maize commercial 
varieties  (referred  to  hereafter  as  “commercial  varieties”).  These  studies  comprise  compositional 
studies, agronomic and phenotypic field studies, stress response studies, persistence and invasiveness 
assessments, and pollen morphology, pollen viability and seed germination tests.
20 For the studies 
conducted under field conditions, the EFSA GMO Panel considers the number of growing seasons and 
the selection of locations included in the experimental design of the comparative  assessment to be 
adequate (for an overview, see  Table 2). Therefore, data from the se studies, taken together, in the 
EFSA GMO Panel’s Scientific Opinion, are considered acceptable for the comparative analyses of 
maize MON 87460 and its conventional counterpart. 
4.1.1.  Choice of comparator 
Maize  lines  DM1718  and  H1548126  were  used  as  comparators  in  the  compositional  studies, 
agronomic  and  phenotypic  field  studues,  stress  response  studies,  persistence  and  invasiveness 
assessments, and pollen morphology, pollen viability and seed germination tests (Table 2). The EFSA 
GMO Panel concludes that both comparators had genetic backgrounds comparable to those of the 
respective lines of maize MON 87460 used in the field studies, as evidenced by the corresponding 
pedigrees.
21 Therefore, these two lines can be regarded as conventional counterparts. 
                                                       
20   Technical Dossier/Section D7.1 and D7.2/Additional information October 2010. 
21   Additional information October 2010. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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Table 2: Overview of comparative assessment studies with maize MON 87460 provided with application EFSA-GMO-NL-2009-70  1 
Study type  Study focus  Study details  Conventional 
counterpart 
Number of 
commercial 
varieties 
Reference 
Section in this 
Scientific 
Opinion 
Field  Composition 
USA 2006 
Six sites under water conditions typical of 
local agronomic practices 
H1548126  18  Harrigan et al. (2008a)  4.1.2 
Field  Composition 
Chile 2006–2007 
Three sites under well-watered and water-
limited conditions 
DM1718  12  Alba et al. (2008); 
Harrigan et al. (2008b)  4.1.2 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2006 
Eight sites under well-watered conditions  H1548126  19  Sammons et al. (2009)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2006 
Five sites under water conditions typical 
of local agronomic practices 
H1548126  15  Whitsel and Clark (2008)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
Chile 2006–2007 
Three sites under well-watered and water-
limited conditions 
DM1718  16  Eberle (2009a)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2007 
Ten sites under well-watered conditions  DM1718  11  Rosenbaum et al (2008)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2007 
Three sites under well-watered conditions, 
of which one was also under water-limited 
conditions 
DM1718  12  Eberle (2009b)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2007 
Three sites under well-watered and water-
limited conditions 
DM1718  7  Sammons et al. (2008)  4.1.3.1 
Field 
Agronomic and 
phenotypic 
characteristics 
USA 2003, 2007 
One site under water-limited conditions 
(USA, 2003); one site under well-watered 
and water-limited conditions (USA, 2007) 
LH59R1 x 
LH200; 
DM1718 
0; 0  Luethy (2009)  4.1.3.1 
Greenhouse  Stress response to 
drought  Exposure to drought treatment  H1548126  0  Chomet et al. (2008)  4.1.3.2 
Greenhouse  Stress response to 
drought  Exposure to drought treatments (4)  DM1718  0  Eberle et al. (2009)  4.1.3.2 Scientific Opinion on genetically modified drought tolerant maize MON 87460 
for food and feed uses, import and processing  
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Study type  Study focus  Study details  Conventional 
counterpart 
Number of 
commercial 
varieties 
Reference 
Section in this 
Scientific 
Opinion 
Greenhouse  Stress response to salt  Exposure to salt treatments (4)  DM1718  0  Whitsel (2008b)  4.1.3.2 
Growth chamber  Stress response to 
heat  Exposure to heat treatments (4)  DM1718  0  Eberle (2008b)  4.1.3.2 
Growth chamber  Stress response to 
cold  Exposure to cold treatments (4)  DM1718  0  Eberle (2008a)  4.1.3.2 
Field  Persistence  USA 2006–2007 
Three sites  H1548126  6  Whitsel (2008a)  6.1.1.1 
Field  Persistence and 
invasiveness 
USA 2007 
Four sites in unmanaged environments  H1548126  7  Rosenbaum and Eberle 
(2008)  6.1.1.1 
Growth chamber  Seed germination  Field-collected seed 
(USA 2006, three sites)  H1548126  9  Whitsel (2007)  6.1.1.1 
Laboratory  Pollen morphology 
and viability 
Field-collected pollen  
(USA 2007, one site under well-watered 
and water-limited conditions) 
DM1718  4  Whitsel and Sammons 
(2008) 
6.1.1.2 
  2 Scientific Opinion on genetically modified drought tolerant maize MON 87460 
for food and feed uses, import and processing  
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4.1.2.  Compositional analysis
22 
4.1.2.1.  Studies under local agronomic practices or well-watered conditions 
Compositional data were collected from field studies in the USA during the growing season 2006 and 
in Chile during the growing season 2006–2007 (Table 2).  
In the USA field study, maize MON 87460 was grown in replicated plots at six sites together with its 
conventional  counterpart  (H1548126)  and  18  commercial  varieties  (three  per  site).
23  The water 
management regime was applied according to local agronomic practice.
24  Both forage and grain 
harvested from maize MON 87460, its conventional counterpart and the commercial varieties were 
assessed by proximate analysis (protein, fat, ash, moisture, carbohydrates by calculation) and for 
specific  fibre  fractions (acid-detergent fibre, neutral-detergent fibre),  as well as for calcium and 
phosphorus. The analysis of grains also included total dietary fib re, amino acids, fatty acids, other 
minerals (Na, K, Mg), trace elements (Cu, Fe, Mn, Zn), vitamins (B1, B2, B6, E, niacin, folic acid), 
and secondary metabolites ( p-coumaric acid, ferulic acid, furfural, raffinose, phytic acid). The 77 
endpoints analysed are in line with the recommendations for key compositional endpoints in new 
varieties of maize (OECD, 2002). 
The results of the compositional analysis of maize MON 87460 were compared with those of the 
conventional counterpart via per-site and combined-site analysis of variance. Fifteen endpoints for 
which more than 50 % of the samples were below the limit of quantification were excluded from the 
statistical analysis. These endpoints included a range of fatty acids that constitute a minor fraction of 
total fatty acids, sodium and furfural. The applicant used the values obtained from the 18 commercial 
varieties to  build  a  99 %  tolerance  interval  (with  95 %  confidence)  (Kotz,  2006)  for  each  of  the 
remaining  62  compositional  endpoints,  to  provide  an  estimate  of  natural  variation  against  which 
differences between maize MON 87460 and its conventional counterpart could be interpreted. The 
EFSA  GMO  Panel  considers  that  this  method  provides  an  estimate  of  the  variation  between 
commercial genotypes that may not always be optimal. This depends on the formulae used to derive 
the estimate and on the design of the study. When none of the commercial varieties are grown at more 
than one site, an estimated tolerance interval may reflect not only variability between genotypes but 
also variability between sites, albeit to a limited extent (see Section 3.3.2 of EFSA, 2010a). The EFSA 
GMO  Panel  considers  that  the  estimated  tolerance  interval  allows  the  observed  differences  to  be 
placed into the context of natural variability.  
In the combined-site analysis of forage, no statistically significant differences were identified between 
maize MON 87460 and its conventional counterpart. In the combined-site analysis of grain, three 
statistically  significant  differences  were  observed  when  comparing  maize  MON 87460  with  its 
conventional counterpart: ash (1.54 % vs 1.46 % dry weight, respectively), stearic acid (2.05 % vs 
1.98 % of total fatty acids, respectively), and eicosenoic acid (0.18 % vs 0.19 % of total fatty acids, 
respectively). Values for these three endpoints in maize MON 87460 were all within their respective 
99 %  tolerance  intervals.  In  the  per-site  analysis,  stearic  acid  was  not  different  at  any  site;  but 
statistically significant differences were observed at only one site for ash and eicosenoic acid. 
The field study conducted in Chile in 2006–2007 included maize MON 87460 grown in replicated 
plots at three sites together with its conventional counterpart (DM1718) and 12 commercial varieties 
(four per site).
25 Both well-watered and water-limited conditions, depending on whether irrigation was 
applied during specific late plant growth stages of maize (V10–R2), were applied.  
Under well-watered conditions, both forage and grains were analysed for 77 compositional endpoints, 
fulfilling the recommendations for key compositional endpoints in new varieties of maize (OECD, 
                                                       
22   Technical Dossier/Sections D7.2 and D7.3. 
23   Technical Dossier/Harrigan et al. (2008a). 
24   Additional information October 2012. 
25   Technical Dossier/Harrigan et al. (2008b). Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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2002). In addition, more specific compositional information on the levels of stress-related biochemical 
maize components, including plant hormones and organic osmolytes, were collected from this field 
study.  The  outcomes  of  these  studies  carried  out  under  water-limited  conditions  are  discussed  in 
Sections 4.1.1.2 and 4.1.1.3. 
Statistical analysis was applied to the compositional endpoints in the same manner as that for the study 
in the USA in 2006–2007: 16 endpoints for which more than 50 % of the samples were below the limit 
of quantification were excluded from the statistical analysis, and the values obtained from the 12 
commercial varieties were used to build a 99 % tolerance interval (with 95 % confidence) for each of 
the remaining 61 compositional endpoints.  
In the combined-site analysis of forage, no statistically significant differences were identified between 
maize  MON 87460  and  its  conventional  counterpart.  In  the  combined-site  analysis  of  grain,  two 
statistically  significant  differences  were  observed  when  comparing  maize  MON 87460  with  its 
conventional  counterpart:  total  fat  (3.89 %  vs  3.72 %  dry  weight,  respectively)  and  magnesium 
(0.12 % vs 0.11 % dry weight). Values for total fat and magnesium were all within their respective 
99 % tolerance intervals. In the per-site analysis, significant differences were observed at only one site 
for both endpoints.  
The observed differences in the various endpoints of the composition of maize MON 87460, compared 
with its conventional counterpart, do not raise safety concerns for humans and animals in the opinion 
of the EFSA GMO Panel, given the estimated natural variation of those endpoints and the magnitude 
of these differences in relation to the characteristics of the pertinent endpoint. 
4.1.2.2.  Studies under water-limited conditions 
As described in Section 4.1.2.1, the field study in Chile was carried out under both well-watered and 
water-limited conditions, focusing on a comprehensive compositional analysis. Under water-limited 
conditions, both forage and grains were analysed for 77 compositional endpoints that are in line with 
the recommendations for key compositional endpoints in new varieties of maize (OECD, 2002). 
In the combined-site analysis of forage, a statistically significant difference was identified for total fat 
(1.32 % vs 0.84 % dry weight, respectively) when comparing maize MON 87460 with its conventional 
counterpart. The value of total fat was within the 99 % tolerance interval. In the per-site analysis, this 
difference was not observed at any site. 
In the combined-site analysis of grain, a small but significant decrease was identified for eicosenoic 
acid (both values equal to 0.18 % of total fatty acids after rounding to two decimals) when comparing 
maize MON 87460 with its conventional counterpart. The value of eicosenoic acid was within the 
99 % tolerance interval. In the per-site analysis, this difference was observed at one site. 
Based on the magnitude of these differences, the estimated natural variation and the characteristics of 
the pertinent endpoints, the EFSA GMO Panel concludes that these compositional differences between 
maize  MON 87460  and  its  conventional  counterpart  do  not  raise  safety  concerns  for  humans  or 
animals. 
4.1.2.3.  Analysis of stress-related compounds 
As described in Section 4.1.2.1, stress-related compounds (organic osmolytes and plant hormones) 
were analysed on forage and grains obtained from the Chilean field study under well-watered and 
water-limited conditions.
26 The analysis of organic osmolytes included free proline, choline, glycine 
betaine and various carbohydrates (fructose, glucose, glycerol, mannitol, sorbitol, sucrose), while that 
of plant hormones included abscisic acid and salicylic acid. Mannitol and sorbitol in both forage and 
grains were below the limit of  quantification in all samples and were therefore excluded from the 
statistical analysis.  
                                                       
26   Technical Dossier/Alba et al. (2008). Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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Under well-watered conditions, in the combined-site analysis of forage, maize MON 87460 showed a 
statistically significantly higher level of abscisic acid compared  with the conventional counterpart 
(37.03 vs 15.66 ppb fresh weight, respectively), which also fell outside the tolerance interval defined 
by the commercial varieties (upper boundary 33.02 ppb). In the per-site analysis, such an increase was 
observed at one site. In the combined-site analysis of grains, no statistically significant differences 
were identified between maize MON 87460 and its conventional counterpart. The observed difference 
for abscisic acid in the combined-site statistical analysis is not considered relevant by the EFSA GMO 
Panel, given the absence of other concomitant changes that would raise safety concerns for humans 
and animals. 
Under water-limited conditions, in the combined-site analysis of forage, no significant differences 
were identified between maize MON 87460 and its conventional counterpart. In the combined-site 
analysis of grain, a statistically significant decrease was identified in the level of sucrose from maize 
MON 87460 compared with the conventional counterpart (1.63 % vs 1.86 % dry weight). The sucrose 
level in grains from maize MON 87460 fell within the tolerance interval. In the per-site analysis, 
sucrose in grains was significantly lower at two sites. The observed difference for sucrose  is not 
considered to raise safety issues for human and animal health, given the magnitude of the change and 
the nature of this compound. 
Having  considered  the  total  set  of  compositional  data  supplied  and  the  observed  compositional 
differences between maize MON 87460 and its conventional counterpart in the light of the field study 
design, the nature and magnitude of the differences and biological variation, the EFSA GMO Panel 
concludes that no biologically relevant differences were identified in the compositional characteristics 
of forage and grains produced by maize MON 87460 compared with its conventional counterpart, and 
that its composition falls within the estimated natural variation, except for the expression of the CspB 
and NPTII proteins. 
The compositional differences between maize MON 87460 and its conventional counterpart under 
water-stressed conditions are not considered relevant for humans or animals by the EFSA GMO Panel, 
based on each particular endpoint studied and the magnitude of the observed difference in relation to 
the characteristics of the endpoint. 
4.1.3.  Agronomic traits and GM phenotype
27 
The  agronomic  and  phenotypic  characteristics  of  maize  MON 87460  compared  with  its  non-GM 
maize  counterpart  were  analysed,  both  in  field  studies  and  under  greenhouse  or  growth  chamber 
conditions.  
4.1.3.1.  Agronomic and phenotypic field studies 
Agronomic and phenotypic field studies with maize MON 87460 were carried out across 31 sites over 
two consecutive years: 13 US sites in 2006; three Chilean sites in 2006–2007; and 14 US sites in 2007 
(Table 2). In all field studies, a randomised complete block or strip design with three replications was 
used.  Fields  studies  were  established  using  three  different  water  management  regimes,  with  field 
studies established under: 
-  well-watered conditions: 8 sites in 2006 and 10 in 2007 in the USA; 
-  water conditions typical of local agronomic practices: 5 sites in 2006 in the USA; 
-  well-watered and water-limited conditions in the same field: 3 sites in 2006–2007 in Chile and 7 
sites in 2007 in the USA. 
In some sites, the stress experienced by plants was varied by including both well-watered (irrigated) 
and water-limited conditions in the field trial. Under well-watered conditions, soil moisture levels 
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were required to attain levels (e.g. 60–85 %) adequate for supporting maize production and hence non-
limiting to yield potential. Under water-limited conditions, water management was transiently (e.g. 
from the V10–R2 until the R4 stage) adjusted during plant development so as to reduce the available 
soil moisture below 50 % (e.g. to 30–40 % soil moisture) as a means of causing stress. A further 
indicator of water stress was the change in certain endpoints in the commercial varieties grown in the 
same experiment, such as a decrease in plant height, ear height or yield, or an extended period until 
50 % silking was achieved. Sufficiently large changes in these endpoints supported the decision to 
accept the field study conditions as being representative of water-limited conditions.  
(a) Comparisons without deliberate application of water stress 
Well-watered conditions were applied in two field studies in 8 and 10 replicated sites in the USA in 
2006 and 2007, respectively.
28 In the 2006 field study, maize MON 87460 was grown together with a 
conventional counterpart (H1548126) and commercial varieties (four lines  at each site, 19 different 
lines in total)  at all sites.
29 In the 2007 field study, maize MON  87460 was grown together with a 
conventional counterpart (DM1718) and  11 commercial varieties.
30 Water management was carried 
out according to local agronomic practices in a parallel field study comparing maize MON 87460 with 
the same conventional counterpart (H1548126) and 15 commercial varieties in total at five replicated 
sites in the USA during the same year (2006).
31 The crop was irrigated at one site and rain fed in the 
four others. Both well-watered and water-limited conditions were applied in one field study with three 
sites in Chile during the 2006 –2007 season
32, and in two field  studies at four and three sites in the 
USA during the 2007 season.
33 In these field studies, maize MON 87460 was grown together with its 
conventional counterpart (DM1718) and varying numbers of commercial varieties (four lines per site). 
In all field  studies, information on phenotypic and agronomic characteristics of maize MON  87460 
and its conventional counterpart was generated to compare their growth habit, vegetative vigour and 
reproduction characteristics. The endpoints that were statistically analysed in various field  studies 
included commonly measured characteristics related to plant development, physiology, and agronomic 
performance. These endpoints included the following: seedling vigour, early stand count, days to 50 % 
pollen shed and silking, stay-green rating, ear height, plant height, dropped ears, stalk lodging, root 
lodging, final stand count, grain moisture, test weight, and yield. Visually observable responses to 
naturally occurring insects, diseases or abiotic stressors were also recorded in order to provide 
indications  of  altered  stress  responses  in  maize  MON 87460  compared  with  its  conventional 
counterpart.  
In the across-site statistical analysis of the results of the well-watered field trials in the USA, maize 
MON 87460 showed a higher number of root-lodged plants than the conventional counterpart (5.6 vs 
1.5 plants per plot), yet this difference fell within the range of values for the commercial varieties. 
This difference in the number of root-lodged plants was not observed in most sites in the per-site 
statistical analysis of root lodging data. For several other endpoints, including various phenotypic, 
agronomic, and arthropod-related endpoints, statistically significant differences were also observed in 
one or two individual sites, but not in all of them.
34 
In the parallel field study in the USA in 2006, in which the water management was according to local 
agronomic practices, no statistically significant differences were observed   in the combined -site 
statistical analysis. In individual sites, several quantitative endpoints showed statistically significant 
differences, with each endpoint being different in not more than a single site (i.e. not in multiple sites). 
The qualitative analysis of arthropod damage showed a qualitative difference in grasshopper damage, 
                                                       
28   Technical Dossier/Rosembaum et al. (2008) and Sammons (2009). 
29   Technical Dossier/Sammons et al. (2009). 
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31   Technical Dossier/Whitsel and Clark (2008). 
32   Technical Dossier/Eberle (2009a). 
33   Technical Dossier/Eberle (2009b), Rosenbaum et al. (2008) and Sammons (2008). 
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being lower for maize MON 87460 than for its conventional counterpart at one site at one observation 
but not at the others, and still within the background range of observations in commercial varieties.
35 
Another field study in the USA was carried out  at three sites in 2007, including two that contained 
well-watered plots and another one that contained both well -watered and water-limited plots (data 
from  the  latter  are  discussed  in  the  subsection  on  water -stressed  trials).  In  this  study,  maize 
MON 87460 showed a statistically significantly lower stay-green value under well-watered conditions 
in the combined-site statistical analysis, while the average values fell within the background range of 
reference values.  The stay-green  value  also showed a statistically significant difference in two 
individual sites in the per -site statistical analysis, being higher for maize MON  87460 than the 
conventional counterpart  at one of these  sites and lower  at another site. A statistically significant 
difference that was observed under well -watered conditions  at  an individual site but not in the 
combined-site statistical analysis was slightly elevated grain moisture in maize MON 87460.
36 
Under the well-watered conditions of another field  study  in eight sites in the USA in 2007, no 
statistically significant differences were found between maize MON  87460 and its conventional 
counterpart in the combined-site statistical analysis of the results. In the p er-site statistical analysis, 
various endpoints showed statistically significant differences  at individual sites (three sites at most), 
such as higher stay-green values in maize MON 87460 in three sites.
37 
Although the  agronomic and phenotypic  data  derived  from field studies  showed a statistically 
significant higher number of root -lodged plants per plot and lower stay -green ratings for maize 
MON 87460 than its conventional counterpart under well-watered or typical watered conditions in the 
combined-site analyses performed per study, these differences were not consistently observed across 
studies and seasons, and fell in the range of values observed for the commercial varieties. Under 
water-limited conditions, maize MON 87460 exhibited lower yields than in wel l-watered conditions 
but higher yields in the combined-site analysis compared with its conventional counterpart, although 
these differences were not consistently observed across studies and seasons. No visually observable 
responses to naturally occurring insects and diseases were recorded in the field studies. 
(b) Studies with application of water stress 
Yield-  and  physiological  stress -related  endpoints  were  measured  in  maize  MON  87460  and  a 
conventional counterpart (LH59   LH200 in 2003; DM1718 in 2007) during a field study in the USA 
at one site with water-limited conditions in 2003 and at another site with both well-watered and water-
limited conditions in 2007. In  2003, maize MON 87460 showed a higher leaf extension rate, while 
under water-limited conditions in 2007, maize MON 87460 showed higher yield, number of grains per 
ear, leaf extension rate and plant height. The higher yield in the last year appeared to relate to both a 
higher number of grains per ear and a (non-significant) higher kernel weight.
38 
Stay-green rating was statistically significantly lower for maize MON 87460 in the water-limited plots 
at one site in the experiment carried out at three sites in the USA in 2007, while also falling below the 
reference range established from the commercial varieties.
39 
No statistically significant differences between maize MON  87460 under both well -watered and 
water-limited conditions were observed in the combined-site statistical analysis of results from another 
field  study  at  two sites in the USA in 2007,   while a number of endpoints showed statistically 
significant differences at one site but not at the other in the per-site statistical analysis.
40 
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In the Chilean field study carried out under water-limited conditions in 2006–2007, a statistically 
significantly increased yield was observed in the combined-site statistical analysis, as well as at one of 
the  three  sites  in  the  per-site  analysis.  This  difference  could  not  be  linked  to  changes  in  other 
agronomic data.
41 
4.1.3.2.  Abiotic stress response studies under greenhouse and growth chamber conditions 
The response of maize MON 87460 and its conventional counterpart to various types of abiotic stress 
was tested under greenhouse and growth chamber conditions.  
-  In two greenhouse studies, maize MON 87460 and its conventional counterpart (H1548126 and 
DM1718)  were  grown  in  pots  and  exposed  to  four  different  drought  treatments  (well-watered 
conditions  and  mild,  moderate  and  severe  drought  conditions)  at  the  V4  growth  stage  of 
development and then continued for 15 days. Eighty maize MON 87460 and 80 control plants were 
placed in a randomised complete block design with 20 replications.
42 Plants were subjected to a 6-
day period of drought and subsequently  allowed to recover, and various physiological endpoints 
related to  photosynthesis (chlorophyll fluorescence), assimilation (CO 2  gas  exchange,  stomatal 
conductance), leaf extension rate (manual and potentiometric measurements), ion leakage from 
leaves, and relative water content of leaves were measured.  
Maize MON 87460 and its conventional counterpart, exposed to well-watered conditions and mild, 
moderate and severe drought conditions, exhibited a dose-dependent pattern of lower plant height, 
growth stage, and fresh and dry weight with increasing water stress. Depending on the treatment, 
differences (such as fewer leaves and lower fresh and dry weight in the well-watered treatment; 
reduced plant height, fewer leaves and higher leaf rolling score in the moderate drought treatment; 
lower leaf rolling score in the severe drought treatment) were observed between maize MON 87460 
and the conventional counterpart. 
-  For the assessment of salt tolerance a similar approach was followed as for the assessment of 
drought tolerance: maize MON 87460 and its conventional counterpart (DM1718) received either 
no,  mild,  moderate  or  severe  salt  treatment  under  greenhouse  conditions  over  12  days  (up  to 
600 mM NaCl/CaCl2 or 58 g salt/pot in the most severely treated group).
43 The measures taken 
during the analyses were the same as for cold and heat  stress testing (see below ,  excluding 
necrosis), while  morphology was  also recorded.  Both maize MON 87460 and its conventional 
counterpart exhibited a dose-dependent pattern of lower plant height, growth stage, vigour and 
fresh and dry weight. Depending on  the treatment, differences (such as lower dry weight in the 
mild salt treatment; increased vigour and chlorophyll content in the moderate salt treatment; lower 
plant height and decreased vigour in the severe salt treatment) between maize MON 87460 and the 
conventional counterpart were observed.  
-  Growth chamber studies were carried out to test the physiological behaviour of maize MON 87460 
and its conventional counterpart (DM1718) under heat and cold stress.
44 Plants at the V3 growth 
stage  were  exposed to  var ious  heat  or  cold conditions  (optimal,  mild,  moderate, or severe 
temperatures for  8 and 5 days, respectively) with 16-hour lighting periods. The heat conditions 
included optimal growth conditions (30 ºC during lighting periods/22 ºC for the remainder), and 
heat conditions ranging from mild to severe (47 ºC/35 ºC) over 5 days. Cold stress was tested in a 
growth  chamber  experiment  with  a  similar  design,  with  conditions  ranging  from  optimal 
(30 ºC/22ºC) to severe (4  ºC/4 ºC)  over  8  days of cold treatment.  Maize MON 87460 and its 
conventional counterpart exhibited a dose-dependent pattern of lower plant height, growth stage, 
vigour and fresh and dry weight with decreasing   or  increasing  temperatures.  No  significant 
differences  were  observed  between  maize  MON 87460  and its  conventional counterpart  in the 
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mild,  moderate  or  severe  cold  treatments.
45  Differences (such  as  greater  number  of  leaves, 
increased dry weight, reduced chlorophyll content and greater fresh and dry weight in the optimal 
temperature treatment; reduced chlorophyll content in the mild treatment; reduced vigour in the 
severe treatment) were observed for plants exposed to high temperature heat stress.
46 
Given the intended trait, the observed differences  were not unexpected, and  did indicate no safety 
concerns. 
4.2.  Conclusion 
Based on the results of a comparative analysis, the EFSA GMO Panel concludes that, besides the 
expression of the CspB and NPTII proteins, some differences were observed in the composition of 
forage and grain produced from maize MON 87460 compared with its conventional counterpart when 
grown under well-watered conditions. Given the magnitude of these changes and the characteristics of 
these endpoints, the EFSA GMO Panel concludes that the observed differences do not raise safety 
concern for humans or animals. The EFSA GMO Panel notes that under water-limited and other 
stressful conditions, maize MON 87460 can show enhanced agronomic performance characteristics 
and some differences in chemical composition in comparison with its conventional counterpart. Given 
the intended trait, the observed differences were not unexpected, and did not raise safety concerns. 
5.  Food/feed safety assessment 
5.1.  Evaluation of relevant scientific data 
5.1.1.  Product description and intended uses
47 
The scope of application EFSA-GMO-NL-2009-70 is for food and feed uses, import and processing of 
maize MON 87460 and all derived products (e.g. starch, syrups, ethanol, maize oil, flakes, coarse and 
regular grits, coarse and dusted meal, flour, maize germ meal, maize gluten feed, condensed steep 
water, and maize gluten meal). 
The genetic modifications in maize MON 87460 are intended to improve agronomic performance only 
and are not intended to influence the nutritional properties, the processing characteristics and  the 
overall use of maize as a crop. 
5.1.2.  Effect of processing
48 
Maize MON 87460 will be used for production and manufacturing of food and feed products in the 
same way as any other commercial maize variety. Some differences were observed in the composition 
of forage and grain produced from maize MON 87460, compared with its conventional counterpart, 
when  grown  under  well-watered  conditions.  Given  the  magnitude  of  these  changes  and  the 
characteristics of these endpoints, the EFSA GMO Panel concludes that the observed differences do 
not raise safety concerns for humans or animals (see Section 4.2), and the effect of processing on 
maize MON 87460 is not expected to be any different from that on conventional maize. 
5.1.3.  Toxicology
49 
5.1.3.1.  Proteins used for the safety assessment 
Owing  to  the  relatively  low  expression  level  of  the  CspB  protein  in  maize  MON 87460  (see 
Section 3.1.3)  and  the  difficulty  of  isolating  a  sufficient  quantity  of  purified  protein  from  maize 
MON 87460, the safety studies with the newly expressed protein were conducted with a CspB protein 
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produced by a genetically modified strain of E. coli, in which the introduced cspB gene encoded an 
amino acid sequence that matched that of the CspB expressed in maize MON 87460.  
The  structural  similarity  and  physicochemical  and  functional  equivalence  of  the  CspB  protein 
produced by E. coli to that produced in grain of maize MON 87460 was demonstrated by N-terminal 
sequencing (Edman degradation), western blot analysis with CspB-specific antibodies, mobility in 
sodium dodecylsulphate–polyacrylamide gel electrophoresis (SDS-PAGE), analysis by matrix-assisted 
laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) of tryptic peptides produced 
from CspB, glycosylation analysis, and purity analysis.
50 A functionality assay was  also carried out 
based on the capacity  for resolving the secondary structures of nucleic acids of CspB.
51 The only 
difference identified was that the protein isolated from  maize MON 87460 is missing the N-terminal 
methionine present in the E. coli-derived CspB protein. As shown by Bradshaw et al. (1998), this type 
of modification is commonly observed in proteins from both prokaryotic and eukaryotic organisms. 
A study
52 was provided that compared the NPTII produced by leaves of maize MON 87460 with the 
NPTII reference standard produced by recombinant E. coli bacteria through western blotting, showing 
that both NPTII proteins displayed immunoreactivity towards specific antibodies and had the same 
apparent molecular weight. 
Based on the identified similarity in structure, and the equivalence in physicochemical and functional 
properties between these proteins, the EFSA GMO Panel accepts the use of bacterially produced CspB 
and NPTII proteins for the degradation studies and safety testing of the newly expressed proteins 
present in maize MON 87460 and as a reference standard in ELISA to estimate expression levels in 
various tissues of maize MON 87460. 
5.1.3.2.  Toxicological assessment of the expressed novel proteins in maize MON 87460 
Various studies have been performed to test the safety and potential toxicity of the newly expressed 
CspB protein in maize MON 87460. The CspB protein is a bacterial protein derived from B. subtilis, 
which is a microorganism of which certain strains are used for the manufacture of food enzymes and 
for the production of fermented soybean products. B. subtilis has been granted the status of “qualified 
presumption of safety  (QPS)” under the condition that food-poisoning toxins are absent from the 
strains used (EFSA, 2011c). The QPS assessment was developed by EFSA to provide a generic risk 
assessment  approach  applicable  across  EFSA’s  scientific  Panels  for  biological  agents  notified  for 
intentional  use  in  the  whole  food  and  feed  chain.  In  essence,  this  approach  comprises  a  safety 
assessment of a defined taxonomic group (e.g. a genus or group of related species) based on four 
pillars:  establishing  identity,  body  of  knowledge,  possible  pathogenicity  and  end  use.  EFSA  has 
previously applied the QPS principle to B. subtilis, for example the use of B. subtilis as a live feed 
additive  (EFSA,  2008,  2011c,  2012).  The  safe  use  of  B subtilis  is  traced  back  to  the  traditional 
fermentation of soybean to make natto (in Japan). 
Cold shock proteins such as CspB occur in a range of prokaryotic and eukaryotic organisms, such as 
lactic acid bacteria present in food and plants. The amino acid sequences of these cold shock proteins 
show a relatively high degree of similarity, despite their phylogenetic distance, indicating that the 
sequence has been conserved relatively well, including the presence of certain RNA-binding segments. 
For example, the sequence of CspB is up to 79 % identical to that in various lactic acid bacteria. CspB 
has the ability to bind to RNA and single-stranded DNA, probably stabilising correctly folded RNA 
structures as “RNA chaperones”, thereby enabling cellular functioning under stressful conditions. 
A study on the presence of CspB in natto, soybeans fermented with B. subtilis strain natto, showed that 
CspB occurred at an average level of 12.5 μg/g in 12 commercial samples analysed for the presence of 
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CspB through ELISA. Western blotting and N-terminal sequence analysis of CspB in two samples 
showed that CspB in natto had the expected size and N-terminal sequence.
53  
(a) Oral toxicity testing 
The potential acute oral toxicity of CspB was tested in mice (strain CD -1). There were no adverse 
effects after administration of a single oral dose of CspB at 4.70 mg/kg body weight.
54  
Considering the knowledge available with respect to the protein’s source, its function and its history of 
human/animal consumption, the EFSA GMO Panel considers that a repeated-dose oral toxicity study 
is not necessary. 
(b) Bioinformatic studies 
In a bioinformatics-supported study, the amino acid sequence of the CspB protein was compared with 
the sequences of toxic proteins and with proteins in general using the FASTA algorithm. No relevant 
similarities between CspB and known toxins could thus be established, while the comparison with 
general proteins revealed that CspB showed a high degree of similarity with cold shock proteins from 
a wide range of organisms.
55 
(c) Pepsin and pancreatin resistance tests  
The resistance of CspB to proteolytic enzymes was tested  in  vitro  using  incubations  of  CspB  in 
solutions with pepsin at pH 1.2 (10 units of pepsin per μg of CspB) and with pancreatin at neutral pH 
(pancreatin:CspB = 55.3  (w/w)).  The  intactness  and  formation  of  peptide  fragments  of  CspB  was 
followed by analysing the incubation mixtures sampled at different time points after initiation by SDS-
PAGE and western blotting. It was observed that, in the presence of pepsin, the full-length CspB 
protein rapidly (within 30 seconds) degraded to below detectable levels (> 99 % degraded), except for 
a  2.5-kDa  fragment  which  was  still  detectable  after  1 hour  of  incubation.  This  fragment  was 
determined  to  be  derived  from  CspB  as  shown  by  N-terminal  sequencing.  When  incubated  with 
pancreatin,  the  full-length  CspB  was  degraded  to  below  detectable  levels  within  5  minutes.  In 
subsequent incubations of CspB with pepsin and pancreatin, the 2.5-kDA fragment was observed to 
disappear within 30 seconds.
56 
(d) Toxicological assessment of the NPTII protein 
A number of studies on the safety of the NPTII protein in this application have already been provided 
previously in the frame of applications for other GM crops expressing newly introduced genes 
encoding the NPTII protein, such as the studies   on acute toxicity of  the  NPTII  protein  and its 
degradation by proteolytic enzymes, and  they are therefore not considered further here by the EFSA 
GMO Panel. An updated bioinformatics study comparing the amino acid sequence of NPTII with 
sequences of toxic proteins failed to find relevant similarities, thus confirming previous outcomes.
57 
The safety of the NPTII protein, which is expressed in maize MON  87460 and serves a role as the 
transformation marker, has been the subject of previous evaluations by the E FSA GMO Panel of the 
safety of other GM crops that also express this protein (maize MON  863 and cotton MON 531 and 
MON 1445, and potato EH92-527-1). The safety data on NPTII provided with the application included 
data previously provided in the frame of other applications, such as an acute oral toxicity study and 
sensitivity of NPTII to degradation by proteolytic enzymes, besides an updated bioinformatics -
supported comparison of the amino acid sequence of NPTII with those of toxic proteins. 
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5.1.3.3.  Toxicological assessment of new constituents other than proteins 
No new constituents other than the CspB and NPTII proteins are expressed in maize MON 87460. No 
biologically relevant changes in the composition of maize MON 87460 were found (Section 4.1.2). 
Therefore, a toxicological assessment of new constituents is not applicable. 
5.1.3.4.  Toxicological assessment of the whole GM food/feed 
Since  no  biologically  relevant  differences  were  identified  in  the  compositional,  agronomic  and 
phenotypic characteristics of maize MON 87460 (Section 4.2), animal safety studies with the whole 
food/feed are not considered necessary by the EFSA GMO Panel. However, the applicant provided a 
report of a subchronic 90-day feeding study with maize MON 87460-containing diets in rats. The 
study  design  was  adapted  from  the  OECD  technical  guideline  408  for  the  testing  of  chemical 
substances in laboratory rodents for 90 days. 
Three groups of 40 Sprague Dawley rats (strain CRL:CD[SD], 20 animals of each gender) were fed 
diets  containing  33 %  maize  MON 87460,  11 %  MON 87460  plus  22 %  of  its  conventional 
counterpart (DM1718) or 33 % maize DM1718. Maize grain harvested from field study in Chile was 
used to formulate the diets. The dietary inclusion of maize MON 87460 was analytically confirmed by 
ELISA for the newly expressed CspB protein. The experimental diets were shown to be equivalent 
concerning nutrient composition and content of heavy metals, mycotoxins and pesticides. 
The  endpoints  analysed  during  and  after  the  experimental  feeding  period  included  clinical 
observations, mortality, body weights, feed consumption, clinical pathology (including haematology, 
coagulation,  serum  chemistry,  and  urinalysis),  and  macroscopic  pathology  (gross  necropsy,  organ 
weight determinations) and microscopic examinations. In the statistical analysis, each of both test 
groups (fed diets containing either 11 % or 33 % maize MON 87460) was compared with the group 
fed a diet containing 33 % DM1718. 
All animals survived the treatment period and there were no relevant clinical signs. Body weights and 
feed consumption were comparable in all groups. Statistically significant differences that occurred 
only in the group fed 11 % maize MON 87460, i.e. higher mean serum alkaline phosphatase activity 
and lower urine specific gravity in females, are not considered treatment related by the EFSA GMO 
Panel, owing to the lack of a dose response. A significantly lower aspartate aminotransferase activity 
in females fed diets containing 33 % maize MON 87460 is not considered by the EFSA GMO Panel to 
be an indication of an adverse effect, of which increased activity would be an indicator. Mean sodium 
serum levels were slightly lower in females of the high-dose group but fell within the range of the 
historical control means. Males in the group fed a diet containing 33 % maize MON 87460 showed a 
significantly lower heart weight, both in absolute terms and as a relative ratio to brain weight but not 
in relation to body weight, and females showed a lower thyroid and parathyroid weight in relation to 
body weight. The mean values fell within the range of the historical control means. There were no 
relevant findings in the histopathological examinations of these organs. Macroscopic and microscopic 
examinations of other selected organs and tissues did not reveal changes related to administration of 
the test materials. The EFSA GMO Panel concludes that there are no indications of adverse effects in 
this study. 
5.1.4.  Allergenicity
58 
The strategies used when assessing potential allergenic risk focus on the characterisation of the source 
of the recombinant protein, the potential of the newly expressed protein to induce sensitisation or to 
elicit allergic reactions in already sensitised persons, and whether the transformation may have altered 
the allergenic properties of the modified food. A weight-of-evidence approach is recommended, taking 
into account all of the information obtained with various test methods,  as no single experimental 
method yields decisive evidence of allergenicity (EFSA, 2006a, 2010b; Codex Alimentarius, 2009). 
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5.1.4.1.  Assessment of allergenicity of the newly expressed proteins 
The source of CspB, B. subtilis, is not known to be an allergen in its own right. Using bioinformatics, 
the amino acid sequence of CspB was compared with the sequences of known allergenic and celiac-
disease-causing proteins. The latter group of sequences had been obtained from an external dedicated 
database with records of individual sequences that had been peer reviewed for data supporting the 
allergenicity of the specific sequence. A FASTA algorithm was applied for alignment of the CspB 
with the database sequences, while the criteria for relevant alignments included a lower threshold of at 
least  35 %  identity  in  an  80-amino-acid  window  or  an  expectation  (E-)  value  below  1   10
–5.  In 
addition, another algorithm was applied to search for matches of short identical segments consisting of 
eight contiguous amino acids. No positive results were returned from this bioinformatics-supported 
comparison.
59 CspB is rapidly hydrolysed by pepsin and pancreatin.
60 
The EFSA GMO Panel notes that a publication in the scientific literature describes the identification 
of a potential cold shock protein encoded by a gene isolated from the mould Cladosporium herbarum, 
which according to the authors is bound by immunoglobulin (Ig) E sera from donors allergic to this 
mould. This 73-amino-acid protein was observed to share 70% similarity with CspB from B. subtilis, 
while IgE serum reactivity with the latter was not tested.
61 At the request of the EFSA GMO Panel, the 
applicant was asked to comment on this issue. Based on the answer received and the data availabl e, 
the EFSA GMO Panel considers that no further accounts of the allergenicity of this protein and other 
cold shock proteins exist, and that the protein has neither been included in the official allergen list of 
the  WHO-IUIS  (World  Health  Organization –Union  of  Immunological  Sciences)  nor  in  protein 
sequence databases. Moreover, a review of fungal allergens considers this mould protein (designated 
Cla h 8 CSP) and various other proteins from the same mould not to be major allergenic components 
in allergy to C. herbarum.
62 Further, the EFSA GMO Panel notes that fungal allergens rarely cause 
food allergy. The EFSA GMO Panel concludes that the risk of an allergic reaction caused by potential 
CspB cross-reactivity with a minor mould allergen is low.  
The potential allergenicity of NPTII has previously been assessed during evaluations of other crops 
expressing  this  protein.  NPTII  was  thus  found  unlikely  to  become  an  allergen.  An  updated 
bioinformatics-supported comparison of NPTII with allergens and celiac-disease-causing proteins also 
failed to find relevant similarities.
63 
Based on this information, the EFSA GMO Pan el concludes  that it is unlikely that these newly 
expressed proteins are allergenic. 
5.1.4.2.  Assessment of allergenicity of the whole GM plant or crop 
According to the EFSA GMO Panel risk assessment guidelines (EFSA, 2006a, 2010b, 2011a), the 
applicant should test any potential change in the allergenicity of the whole GM plant by comparing the 
allergen repertoire with that of its appropriate comparator(s), when the plant receiving the introduced 
gene is known to be allergenic. In this context, maize is not considered to be a common allergenic 
food (EC, 2007). 
The prevalence of food allergy to maize is low and appears to vary with the geographic location 
(Moneret-Vautrin et al., 1998; Pastorello et al., 2009; Fonseca et al., 2012). At least 23 IgE-binding 
proteins have been identified in maize, a number of which are recognised as allergens. Sixteen of these 
proteins have been reported to be stress related, with LTP (lipid transfer protein) being the most 
important allergen in the Mediterranean region (Pastorello et al., 2000; Pasini et al., 2002; Pastorello et 
al., 2009; Fonseca et al., 2012). In some studies, most individuals with a positive skin prick test (SPT) 
or having IgE antibodies against maize were suffering  from a respiratory allergy and only a few 
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displayed a true food allergy upon oral challenge with maize products (Jones et al., 1995; Pasini et al., 
2002). In another study of 27 patients with a claimed history of maize allergy one-half were found to 
be challenge-positive and thus had a food allergy to maize (Scibilia et al., 2008). 
Compositional analysis of stress-related compounds in grains did not show significant changes that 
would suggest alterations in the expression of stress-related allergenic proteins. 
Bioinformatics analyses of the DNA sequence at the insertion sites did not indicate (1) an insertion 
within or near a known endogenous gene (potential allergens); or (2) creation of ORFs at the insert–
plant DNA junctions that are likely to be translated into allergenic peptides (Section 3.1.2). 
In the context of the present application, there is no evidence that the genetic modification might 
significantly change the overall allergenicity of maize MON 87460. 
5.1.5.  Nutritional assessment of GM food/feed
64 
As only minor differences were observed in the composition of forage and grain produced from maize 
MON 87460 compared with its conventional counterpart, the EFSA GMO Panel considers that the 
nutritional properties are likely to be essentially the same as those of other maize. 
Apart from these considerations, a 42-day feeding study with chickens was carried out. After a 7-day 
pre-period,  800  chickens  for  fattening  (Ross   Ross  308,  both  genders)  were  distributed  to  eight 
treatments (5 replicates with 10 birds each of each gender per treatment) fed diets containing maize 
MON 87460, the conventional counterpart (DM1718) or maize from 6 commercial varieties. Animal 
housing and management of the study followed the principles and guidelines for care and use of 
agriculture  animals  in  research  (FASS,  1999).  The  diets  were  formulated  according  to  nutrient 
requirements (NRC, 1994), adjusted for nutrient and energy content, contained 58.7–59.7 % maize in 
the starter period (days 1–21) and 62.7–63.7 % maize in the grower/finisher period. All corn sources 
and the diets were comprehensively analysed to ensure nutritionally equivalent concentrations. At the 
end of the study, body weight and feed intake were determined, the birds slaughtered (males on day 
43,  females  on  day  44),  and  carcass  parameters  determined.  A  two-factorial  analysis  of  variance 
(factors: diet and sex) was used for statistical assessment of all endpoints. Afterwards adequate tests 
were used to compare individual treatments. Total losses during the experimental period amounted to 
an average of 6.9 % (maize MON 87460: 6.7 %). 
Final body weight for both sexes was 2.71 kg, the treatments ranging between 2.65 an 2.72 kg (maize 
MON 87460: 2.71 kg). The feed intake varied between 4.19 and 4.38 kg/broiler (maize MON 87460: 
4.38 kg) and the feed to gain ratio between 1.61 and 1.65. Feed to gain ratio for the group with maize 
MON 87460  was  1.64  and  significantly  higher  than  that  of  the  control  group  (DM1718:  1.61). 
However,  the  difference  is  considered  small  by  the  EFSA  GMO  Panel  and  not  indicative  of  a 
nutritional imbalance of biological relevance. No significant differences between the treatments were 
found concerning carcass quality. 
In summary, the results of the study on chickens for fattening concerning zootechnical performance 
support the conclusion that maize MON 87460 can be used in the same way as other maize sources as 
a feedingstuff in animal nutrition. 
5.1.6.  Post-market monitoring of GM food/feed
65 
The risk assessment concluded that no data have emerged to indicate that maize MON 87460 is any 
less  safe  than  its  conventional  counterpart.  In  addition,  maize  MON 87460  is  as  nutritious  as 
commercial varieties. Therefore, and in line with its risk assessment guidelines (EFSA, 2011a), the 
EFSA GMO Panel considers that post-market monitoring of the GM food/feed is not necessary. 
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5.2.  Conclusions 
An appropriate set of data of has been considered by the EFSA GMO Panel for the evaluation of the 
safety of both the newly expressed proteins and the whole food/feed derived from maize MON 87460, 
as summarised in Section 5.1. 
The  newly  expressed  protein  CspB  occurs  naturally  in  B. subtilis,  of  which  some  strains  have 
applications in the production of food or food constituents. Moreover, proteins very similar to CspB 
occur in a wide range of organisms, including microorganisms such as lactic acid bacteria used for 
food fermentation. CspB was found to occur, for example, in a fermented soybean food. The amino 
acid sequence of CspB did not show any relevant similarity with known toxins. The full-length CspB 
protein was rapidly degraded by proteolytic enzymes. The newly expressed NPTII has previously been 
evaluated for its safety in the frame of previous applications for crops expressing this protein (e.g. 
maize MON 863, cotton 531 and 1445, and potato EH92-527-1) and no safety issues were identified. 
An updated bioinformatics comparison of NPTII with toxins revealed no new information and further 
confirmed the previous conclusions on its safety. 
For  the  assessment  of  potential  allergenicity  of  CspB,  the  internationally  harmonised  weight-of-
evidence approach was applied. The source of CspB, B. subtilis, has no history of allergenicity. CspB 
is  rapidly  hydrolysed  by  pepsin  and  pancreatin.  Its  amino  acid  sequence  did  not  show  relevant 
similarities with allergens.  
Diets containing grain derived from maize MON 87460 were fed to rats during a subchronic feeding 
study, and no indications of toxicity were found. In addition, there is no evidence that the genetic 
modification  might  significantly  change  the  overall  allergenicity  of  maize  MON 87460.  The 
compositional  data  indicating  the  nutritional  equivalence  of  maize  MON 87460  were  further 
corroborated by the outcomes of a nutritional feeding study in chickens. 
In conclusion, the EFSA GMO Panel considers that maize MON 87460 is as safe and as nutritious as 
its conventional counterpart and non-GM commercial varieties, in the context of its intended use. 
6.  Environmental risk assessment and monitoring plan 
6.1.  Evaluation of relevant scientific data 
6.1.1.  Environmental risk assessment 
The scope of the application is for food and feed uses, import and processing of maize MON 87460 
and  does  not  include  cultivation.  Considering  the  intended  uses  of  maize  MON 87460,  the 
environmental risk assessment is concerned with the accidental release into the environment of viable 
grains  from  maize  MON 87460  during  transport  and  processing,  and  with  the  exposure  through 
manure and faeces from animals fed maize MON 87460. 
6.1.1.1.  Effects on plant fitness due to the genetic modification 
A series of agronomic and phenotypic field studies with maize MON 87460 was carried out using 
three  different  water  management  regimes,  with  field  studies  established  under:  (1)  well-watered 
conditions; (2) water conditions typical of local agronomic practices; and (3) well-watered and water-
limited conditions in the same field (Section 4.1.3.1; Table 2). Under water-limited conditions, maize 
MON 87460 exhibited lower agronomic performance characteristics (e.g. yield) than in well-watered 
conditions but showed enhanced agronomic performance characteristics across locations compared 
with its conventional counterpart, although these differences were not consistently observed across 
studies and seasons. No biologically relevant differences in visually observable responses to naturally 
occurring insects and diseases were recorded in the field studies.  
Abiotic (drought, cold, heat and salt) stress tolerance of maize MON 87460  was evaluated under 
greenhouse or growth chamber conditions in various studies (Section 4.1.3.2; Table 2). Depending on Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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the treatment, differences were observed between maize MON 87460 and its conventional counterpart. 
Given the intended trait, the observed differences were not unexpected, and did indicate no safety 
concerns. 
An additional field study with maize MON 87460, its conventional counterpart (H1548126), and six 
non-GM maize commercial varieties was conducted at three locations during 2006–2007 in the USA 
to  assess  the  persistence  (overwintering  and  volunteer  potential)  of  maize  MON 87460,  using  a 
randomised complete block design with three replications (Table 2).
66 In this field study, seeds were 
planted in autumn (November 2006) and the occurrence of volunteer maize plants was surveyed in the 
autumn of 2006 and spring of 2007, while the fields  were maintained according to local agricultural 
practice. No volunteer maize plants were observed at any site or observation time.  
In 2007, additional field studies with maize MON 87460 and its conventional counterpart (H1548126) 
and non-GM maize commercial varieties (three per location, seven different lines in total) were carried 
out at four locations in the USA to assess  the persistence and invasiveness (competitive) ability of 
plants from F2 seed of maize MON 87460 (Table 2).
67 A randomised complete block design with three 
replications was implemented. Each location was unmanaged and received no agricultural inputs, 
allowing maize MON 87460, its comparator and non-GM maize commercial varieties to compete with 
existing vegetation and abiotic and biotic s tressors present in each environment. Endpoints analysed 
included early stand count, vigour (at five different growth stages), late vegetative plant height, final 
stand count, final plant height, number of ears per plant and per plot, and number of seeds per plot. For 
most endpoints, no differences were observed between maize MON  87460 and its conventional 
counterpart; for early and final stand count greater values were reported for maize MON  87460 than 
for its conventional counterpart. In one location, no maize seedlings emerged at all, while in one out of 
the three remaining locations, maize plants reached the seed-setting stage of development. In the latter 
location, both early and final stand counts were statistically significantly higher for maize MON 87460 
than for the conventional counterpart. The average replacement values (ratio of the number of seed 
produced to the number of seeds sown) for seed produced from all maize varieties grown in this 
location were low (< 1), indicating that less seed was pr oduced in the location than had previously 
been sown there, and that the maize population was declining. 
Seed germination tests with seeds harvested from maize MON  87460, its conventional counterpart 
(H1548126), and non-GM maize commercial varieties that had been grown in three locations in the 
USA in 2006 were performed to evaluate seed characteristics under growth chamber conditions 
(Table 2).
68 Seeds were incubated in germination chambers in the dark using different temperature 
regimes: temperatures ranging between 5 ºC and 30 ºC or temperatures alternating between 10 ºC (16 
hours) and 20 ºC (8 hours), and between 10 ºC and 30 ºC, over 12 days. Other seeds were subject to a 
temperature regime alternating between 20 ºC and 30 ºC, according to the Association of Official Seed 
Analysts (AOSA) protocol, over 7 days. Endpoints analysed included the number of germinated seed 
(including a distinction between normal and abnormal germinated seed for seeds incubated according 
to the AOSA protocol), hard seed, dead se ed and firm swollen seed. N o statistically significant 
differences in germination characteristics (dead, germinated, viable swollen and viable hard) were 
found between maize MON 87460 and its comparator. In the combined-location statistical analysis, no 
statistically significant differences were observed between maize MON  87460 and its conventional 
counterpart. Because of a significant location    genotype interaction for germinated and viable firm 
swollen seed at 10 ºC, the results for these endpoints wer e statistically analysed on a per -location 
basis. It showed that the number of germinated seed was higher, while the number of viable firm 
swollen seed was lower, for maize MON  87460 than its conventional counterpart in seed from one 
location, with the values for maize MON 87460 falling within the background range of values for the 
non-GM maize commercial varieties. 
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The  breeding  pedigree  of  maize  MON 87460  and  its  conventional  counterparts  provided  by  the 
applicant confirmed that the comparators used in the persistence and invasiveness assessments, and 
seed germination tests had a comparable genetic background with maize MON 87460 (Table 2).
69 
Therefore, these two lines can be regarded as conventional counterparts. 
Overall, the data presented in the applicati on do not show biologically relevant differences in plant 
characteristics that indicate altered fitness, persistence  or invasiveness of maize MON 87460 plants, 
compared with its conventional counterpart (see also Section 4.1.3). Under water-limited conditions, 
maize MON 87460 exhibited lower agronomic performance characteristics (e.g. yield)  than in well-
watered conditions but  enhanced agronomic performance characteristics across locations compared 
with its conventional counterpart,  although these differences were not consistently observed across 
studies and seasons. Further, no biologically relevant differences in biotic and abiotic stress responses 
were found between maize MON 87460 and its conventional counterpart after exposure to a range of 
stress levels imposed during early vegetative growth stages.  Therefore,  the EFSA GMO Panel 
considers it very unlikely that the establishment, spread and survival of maize MON  87460 would be 
increased by the drought tolerance trait. Maize is highly domesticated and generally unable to survive 
in the environment without management intervention. Maize plants are not winter hardy in many 
regions of Europe; furthermore, they have lost their ability to release seeds from the cob and they do 
not occur outside cultivated land  or disturbed habitats in agricultural landscapes of Europe, despite 
cultivation for many years. In cultivation, maize volunteers may arise under some environmental 
conditions (mild winters). Observations made on cobs, cob fragments or isolated grains shed  in the 
field during harvesting, indicate that grains may survive and overwinter in some regions, resulting in 
volunteers in subsequent crops. The occurrence of maize volunteers has been reported in Spain and 
other European regions (Gruber et al., 2008). Ho wever, maize volunteers have been shown to grow 
weakly and flower asynchronously with the maize crop (Palaudelmàs et al., 2009). Survival of maize 
plants outside cultivation in Europe is mainly limited by: a combination of low competitiveness;  the 
absence of a dormancy phase; and susceptibility to plant pathogens, herbivores and cold climatic 
conditions. Since these general characteristics are unchanged in maize MON 87460, drought tolerance 
alone is not likely to provide a selective advantage outside cultiv ation in Europe. Therefore, it is 
considered very unlikely that maize MON 87460 will differ from conventional maize varieties in its 
ability  to  survive  into  subsequent  seasons  or  to  establish  feral  populations  under  European 
environmental conditions. 
The EFSA GMO Panel is not aware of any scientific report of increased establishment, spread or any 
change in survival capacity including overwintering of maize MON 87460 or maize with comparable 
properties.  
Maize MON 87460 can show enhanced agronomic performance characteristics (e.g. yield) compared 
with its conventional counterpart under water -limited conditions but has no other altered survival, 
multiplication or dissemination characteristics. Therefore, the EFSA GMO Panel  considers that the 
likelihood of unintended environmental effects owing to the accidental release into the environment of 
viable grains from maize MON 87460 will not differ from that of its conventional counterpart and 
non-GM maize commercial varieties. 
6.1.1.2.  Gene transfer
70 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer of DNA, or vertical gene flow via seed dispersal and cross -
pollination.  
(a) Plant to bacteria gene transfer 
                                                       
69 Additional information October 2010. 
70 Technical Dossier/Additional information October 2010 and April 2012. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
for food and feed uses, import and processing  
 
 
29  EFSA Journal 2012;10(11):2936 
DNA of plants could hypothetically be acquired by bacteria through horizontal gene transfer. Current 
scientific evidence indicates that the transfer of genes derived from GM plants into bacteria and their 
stable integration either has not occurred or, if it has occurred, it has been below the limit of detection 
in all the studies performed (see EFSA, 2009 and references therein).  
The  probability  of  horizontal  gene transfer  of  plant  DNA  (including  the insert  DNA)  to  exposed 
bacteria is determined by the following factors: (1) the amount and quality of plant DNA accessible to 
bacteria in receiving environments; (2) the presence of bacteria with a capacity to develop competence 
for natural transformation, i.e. to take up extracellular DNA; (3) the ability for genetic recombination 
by which the plant DNA can be incorporated and thus stabilised in the bacterial genome (including 
chromosomes and plasmids); and (4) the expression and the function of the protein in the bacterial 
recipient and potential for selection of the acquired transgene-encoded traits.  
The EFSA GMO Panel considers the exposure of bacteria to the insert DNA of maize MON 87460 
(containing the nptII and cspB genes) and the barriers to and the impact of hypothetical horizontal 
gene transfer in receiving environments. Special emphasis was put on whether horizontal gene transfer 
of the nptII gene of maize MON 87460 could lead to kanamycin- and neomycin-resistant bacteria 
emerging  in  some  environments,  especially  the  gastrointestinal  tract  or  faeces,  under  selective 
conditions  (usage  of  the  corresponding  antibiotics
71),  and could  contribute to the environmental 
prevalence of nptII genes.  
(i) Exposure to DNA 
The scope of this application is for food and feed uses, import and processing and excludes cultivation 
in the EU. Therefore, the route of DNA exposure is through consumption of  maize MON 87460 
material.  Furthermore,  exposure  may  occur  via  accidental spillage  into the  environment  of  maize 
MON 87460 grains during transport and processing. Of all the maize commodities imported into the 
EU,  whole  maize  grains  and  maize  flour  are  those  that  most  conceivably  could  contain  DNA 
fragments of sufficient size to encompass full-length gene sequences. In the other maize commodities, 
such as maize gluten feed and meal, dregs from brewing and distilling and maize oil, the plant DNA is 
not detectable or intensively degraded to fragments with estimated lengths < 1500 bp (Rausch and 
Belyea, 2006; Rizzi et al., 2012).
72 Therefore, the possible source of full -length genes from maize 
MON 87460 to bacteria would mainly be limited to unprocessed whole grain , partially digested or 
spilled during transit, and to maize flour.  
DNA present in food and feed becomes substantially further degraded through digestion in the human 
or animal gastrointestinal tract by host and microbial factors, and the likelihood that a full-length gene 
sequence would persist is very low in the lower intestinal tract (se e references in Rizzi et al., 2008 , 
2012; EFSA, 2009). 
Because seed spillage is a random event, predicting levels of exposure through this route is difficult. 
However, the vast majority of plant DNA is expected to be degraded after soil entry  by microbial 
DNases in the soil environment. Plant DNA is considered  a non-persistent component of the DNA 
pool in soil (Levy-Booth et al., 2007; Gulden et al., 2008).  Thus, extracellular DNA (including the 
insert DNA of maize MON  87460) in gastrointestinal tracts, soi l or other environments is present 
transiently, and mainly as short fragments at relatively low concentrations. 
(ii) Bacterial DNA uptake and stabilisation 
The potential to develop competence for natural transformation is widely distributed among bacteria 
of different taxonomic affiliation and environmental prevalence (see Rizzi et al., 2008; EFSA, 2009; 
Rizzi et al., 2012; Seitz and Blokesch, 2012). Some studies have shown that introduced bacteria can be 
transformed naturally in the oral cavity of humans and animals (see Andersen et al., 2001; Hay et al., 
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2002; EFSA, 2009), but competence development and transformation of bacteria by genomic DNA of 
plants has not been observed in the lower gastrointestinal tract even with optimised model systems 
providing a selective advantage (Nordgård et al., 2007; Rizzi et al., 2008; EFSA, 2009; Nordgård et 
al., 2012). Furthermore, not all species have the same degree of competence. Current knowledge 
suggests that most Enterobacteriaceae are not naturally transformable (Johnsborg et al., 2007; Sinha 
and Redfield, 2012).  
Once the plant DNA is taken up by a bacterial cell, it must integrate into the recipient genome to 
persist  during  host  replication.  On  a  theoretical  basis,  this  stabilisation  would  be  based  on  non-
homologous recombination events that do not require similarity between the recombining plant and 
bacterial DNA molecules. Non-homologous recombination has rarely been described in bacteria (de 
Vries et al., 2004; Hulter and Wackernagel, 2008; EFSA, 2009), and has not been detected in studies 
that have exposed bacteria to high concentrations of DNA from GM plants (EFSA, 2009). As non-
homologous  recombination  is  a  major  barrier  for  horizontal  gene  transfer,  non-homologous 
recombination scenarios for the integration for nptII and cspB genes in maize MON 87460 are not 
further considered here. 
While integration  via  non-homologous  recombination  is  most  unlikely,  gene  integration  via  other 
mechanisms may be facilitated by the gene context (i.e. the surrounding/neighbouring sequences) of 
the transgene(s) in the plant (EFSA, 2009). Maize MON 87460 contains DNA sequences that might 
enhance  stabilisation  of  the  nptII  and  cspB  genes  in  the  genome  of  specific  groups  of  bacteria. 
Therefore, the risk assessment below considers three different scenarios for horizontal gene transfer 
(termed hereafter as scenarios of integration) of the transgenes of maize MON 87460 to bacteria in the 
environment (Section 3.2): (1) acquisition of the nptII gene through recombination at the loxP sites 
into bacteria providing Cre or Cre-like recombinases; (2) acquisition of the nptII gene through double 
homologous  recombination  involving  bacterially  derived  sequences  to  Agrobacterium  strains 
containing an octopine-type Ti-plasmid; and (3) gene substitution of the cspB and nptII genes through 
homologous recombination.  
1.  Assessment of the stabilisation of the nptII gene from maize MON 87460 to bacteria through 
Cre-meditated site-specific recombination at the loxP sites 
In maize MON 87460, the nptII gene is flanked by two loxP sites, being part of the bacteriophage P1-
related  site-specific  recombination  system.  The  possibility  that  P1-mediated  recombination  could 
enhance  the  probability  of  horizontal  transfer  of  the  loxP-nptII-loxP  cassette  to  bacterial  cells  is 
investigated below.  
The bacteriophage P1 site-specific recombination system consists of two components: loxP is the site 
on the phage DNA at which recombination occurs and Cre is the phage-encoded protein that carries 
out this recombination between two loxP sites regardless of whether the conformation of the double-
stranded DNA (dsDNA), is supercoiled, a relaxed circle or linear (Ambreski and Hoess, 1984).  
Uptake of DNA by natural transformation typically results in single-stranded DNA (ssDNA) passing 
the  bacterial  membrane  (Krüger  and  Stingl,  2011).  The  fate  of  this  ssDNA  in  the  cell  after 
transformation  is  still  unclear.  Reannealing  of  complementary  ssDNA  fragments  in  the  bacterial 
cytoplasm  can  theoretically  occur  (Saunders  and  Guild,  1981;  Lorenz  and  Wackernagel,  1994; 
Domingues et al., 2012). Complementary DNA strands have been reported as dsDNA within the 
bacterial cell wall and within the transformed bacterial cell (Sun et al., 2009).  
To  become  a  substrate  for  Cre-recombinases,  DNA  must  be  double  stranded  (Guo  et  al.,  1997). 
Double-stranded  DNA,  however,  would  be  vulnerable  to  the  action  of  restriction/modification 
systems, including the phage-related system typical of bacteriophage P1 and related phages (Łobocka 
et al., 2004), competing with the recombination process.  
The potential for horizontal transfer of the loxP-nptII-loxP fragment in maize MON 87460 to bacteria 
depends on the presence of Cre or Cre-like recombinases in the exposed competent bacterial cells, 
which is related to the presence of P1 or P1-like bacteriophages. Bacteriophage P1 is capable of 
plaque formation in several species within the Enterobacteriaceae. The Enterobacteriaceae encompass Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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a  diversity  of  bacterial  species  belonging  to  the  gut  microbiota,  including  pathogenic  E.  coli, 
Salmonella and Shigella. Studies indicate that bacteriophage P1 and related sequences are not only 
present in the gut but also in other environments (Jensen et al., 1998; Breitbart et al., 2002; Balding et 
al., 2005; Hazen et al., 2007).  
Site-specific Cre-mediated recombination has been shown to occur between sites of varying degrees of 
sequence similarity to loxP with a high frequency in vitro (Hoess et al., 1982; Sauer, 1992, 1996; 
Thyagarajan et al., 2000; Corneille et al., 2003). Cryptic sites containing as few as 14 out of 34 bases 
in common with loxP have been shown to be effective (Sauer, 1996; Siegel et al., 2001; Chatterjee et 
al., 2010). On the contrary, Adams et al. (2002) found that Cre recombinase substrate specificity in E. 
coli is much higher in vivo than in vitro. This is in agreement with the reports that bacteriophage P1 
rarely integrates into the chromosome at the loxB site of its host in its lysogenic mode (Hoess et al., 
1982; Asteri et al., 2011; Popa et al., 2011) but maintains itself as an autonomous single-copy plasmid. 
It has been suggested that DNA structure, ionic conditions in vivo and/or the influence of host protein 
factors might have an impact (Seveno et al., 2002; MacDonald et al., 2008). The main action of Cre 
recombinase is excision that occurs several magnitudes more frequently than insertion (Sauer and 
Henderson, 1990; Missirlis et al., 2006).  
Because chromosomal insertion of P1 or P1-like bacteriophages at the loxB site is rarely encountered, 
it is assumed that recombination of the loxP-nptII-loxP fragment would also preferentially occur into 
the loxP site of the P1 circular bacteriophage. However, insertion into the P1 circular molecule creates 
an extra loxP site that would lead to instability of the insertion because of the excision activity of Cre 
(Sauer and Henderson, 1990; Missirlis et al., 2006). Excision would lead to a circular small molecule 
encoding nptII that is expected to be lost during bacterial replication. 
Integration  of  the  loxP-nptII-loxP  into  the  genome  would  be  unlikely  because  of  the  preferential 
insertion  into  the  loxP  site  of  the  P1  or  P1-like  bacteriophage  and  would  coincide  with  the 
chromosomal insertion of P1 into the loxB site. The insertion of P1 in the loxB site of E. coli would 
create loxR and loxL sites. The loxR site has low recombination potential, whereas the loxL site is 
highly recombinogenic. In the case in which chromosomal insertion of the loxP-nptII-loxP fragment 
would  occur,  it  would  be  preferentially  at  the  loxL  site.  When  introduced  into  the  loxL  site,  the 
insertion  would  be unstable  because  two  highly  recombinogenic  sites  would be  created  in  which 
excision would be the main activity (Sauer and Henderson, 1990; Missirlis et al., 2006). Excision 
would lead to a circular small molecule encoding nptII lacking a replication origin, which is expected 
to be lost during bacterial replication.  
2.  Assessment of the stabilisation of the nptII gene from maize MON 87460 to bacteria through 
double  homologous  recombination  involving  bacteria-derived  sequences flanking  the  nptII 
coding sequence in maize MON 87460  
Homologous recombination facilitates the integration of non-mobile, chromosomal DNA fragments 
into bacterial genomes (EFSA, 2009 and references therein). This process depends on the presence of 
stretches of identical DNA sequences between the recombining DNA molecules.  
For maize MON 87460, the probability of transfer of nptII by homologous recombination, through the 
sequences present in the nptII flanking regions as shown by bioinformatic analyses, should be limited 
to A. tumefaciens. A. tumefaciens commonly occurs in agricultural soils and has been reported to be 
naturally competent in soil (Bertolla and Simonet, 1999; Demanèche et al., 2001). BLASTn analysis73 
revealed the possibility of a double homologous recombination between sequences upstream and 
downstream of the nptII gene in maize MON 87460 with the same sequences present on the octopine-
type Ti-plasmid of A. tumefaciens. The sequences involved are: (1) upstream of the nptII the T-tr7 – 
intervening sequence (612 bp); and (2) downstream of the left border – intervening sequence (367 bp). 
Homologous  recombination  between  these  sequences  and  the  homologous  sequences  in  the 
A. tumefaciens Ti-plasmid would result in the insertion of the nptII expression cassette (P35S/nptII/T-
nos) and the concomitant loss of the gene 5 coding sequence of the Ti-plasmid.  
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3.  Assessment  of  gene  substitution  of the  nptII  and  cspB  genes  from  maize  MON 87460  to 
bacteria through homologous recombination 
The nptII and cspB genes in maize MON 87460 are derived from E. coli and B. subtilis, respectively, 
and their presence in environmental bacteria with homologous DNA sequences of both genes can be 
expected,  so  that  theoretically  recombination  between  these  genes  from  maize  MON 87460  and 
members of natural microbial communities could take place.  
(iii) Likelihood of expression and selective advantage  
nptII gene: The expression of the acquired DNA is a prerequisite to produce a risk-relevant change in 
the phenotype of the transformed bacteria. If the nptII cassette from maize MON 87460 is transferred 
to  bacterial  cells,  the  expression  of  the  gene  cannot  be  excluded  because  the  35S  promoter 
(Section 3.1.1) has been shown to be functional in some bacteria (Assaad and Signer, 1990; Lewin et 
al., 1998; Jacob et al., 2002). 
A positive directional selection is considered to be required for rare horizontal gene transfer events to 
represent  biologically  meaningful  scenarios  in  the  risk  assessment,  as  bacterial  communities  are 
continually exposed to a high diversity of other sources of DNA in the environment. However, there is 
limited information about the spatial and temporal variability in the selective conditions that would 
favour  antibiotic-resistant  bacteria,  and  in  the  occurrence,  transferability  and  distribution  of  nptII 
genes in different environments. Also, there is a lack of experimental data on horizontal gene transfer 
from maize MON 87460.  
For the nptII gene of maize MON 87460, owing to the alternative gene transfer scenarios described 
above, both gene substitution and acquisition of the gene by recipients with the nptII gene would be 
possible. The presence of nptII genes in bacteria in environments exposed to maize MON 87460 in the 
context of its intended uses can be expected, but in those recipients the substitution of their natural 
nptII gene by the nptII gene of maize MON 87460 (scenario 3, see above) would not confer a novel 
trait, and thus not provide an additional selective advantage.  
In contrast, the acquisition of the nptII gene by bacteria without nptII genes (scenarios 1 and 2, see 
above) could confer resistance to kanamycin or neomycin, and thus provide a selective advantage in 
habitats in which these antibiotics would be present, i.e. the gastrointestinal tract of animals receiving 
kanamycin or neomycin orally (EFSA, 2009), or soils supplied with faecal matter containing antibiotic 
residues in sufficient concentration (Nap et al., 1992).  
For the specific case of A. tumefaciens (scenario 2, see above), a double homologous recombination 
would  lead  to  the  loss  of  gene 5  from  the  Ti-plasmid.  This  deletion  should  cause  a  selective 
disadvantage for A. tumefaciens as the tumour induction on plants will be impaired (Körber et al., 
1991). In addition, further dissemination of the Ti plasmid to bacteria would be limited to the relatives 
of  Agrobacterium  within  the  Rhizobiaceae  owing  to  the  host  range  specificity  of  the  Ti  plasmid 
(Holsters et al., 1978; Cook et al., 1997; Teyssier-Cuvelle et al., 1999).  
In the case of scenario 1, the EFSA GMO Panel considers that the stabilisation of the loxP-nptII-loxP 
fragment  due  to  the  Cre  recombination  system  present  in  bacteria  containing  a  P1  or  P1-like 
bacteriophage is unlikely. Even in the case that integration would occur, as the main action of the Cre 
recombinase is excision, this would result in the formation of a circular small molecule encoding nptII, 
which would be expected to be lost during bacterial replication owing to the absence of an origin of 
replication. 
The contribution of horizontal gene transfer of the recombinant nptII gene to the development and 
proliferation of antibiotic-resistant bacteria should be seen in the context of the naturally ongoing 
resistance  gene  transfer  between  bacteria,  which  is  several  orders  of  magnitude  more  frequent 
(Brigulla and Wackernagel, 2010). The frequency of horizontal gene transfer of the recombinant nptII 
gene must likewise be regarded relative to the natural distribution and prevalence of nptII genes on 
mobile genetic elements in bacteria. Bacteria carrying the nptII gene on mobile genetic elements are 
found in various environments, although with large spatial and temporal fluctuations (EFSA, 2009). 
Moreover, resistance genes other than nptII also lead to the distribution and prevalence of kanamycin- Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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and  neomycin-resistant  bacteria  in  various  environments.  Considering  the  naturally  occurring 
processes of horizontal gene transfer among bacteria populations and the prevalence of  nptII and 
kanamycin-/neomycin-resistant bacteria, the contribution of a theoretically possible transfer of nptII 
from  maize  MON 87460  to  the  environmental  prevalence  of  kanamycin-  and  neomycin-resistant 
bacteria can, if it exists at all, be only extremely low.  
cspB gene: Regarding the cspB gene, which is regulated by an eukaryotic plant promoter and contains 
a plant intron in maize MON 87460, it is unlikely that it would be expressed in bacteria. In B. subtilis 
and also in other bacteria, of which some may occur in environments exposed to maize MON 87460 in 
the context of its intended use (e.g. the gastrointestinal tract), the cspB gene encodes for a cold shock 
protein that may enhance the viability of its owners under certain conditions of stress, e.g. at low 
temperatures. However, for bacteria transformed with the  cspB gene from maize MON 87460, no 
selective advantage is anticipated because recombination would result only in the replacement of the 
gene in a natural host and thus no novel property would be conferred.  
(iv) Risk conclusion 
The  EFSA  GMO  Panel  concludes  that  adverse  effects  on  human  and  animal  health  and  the 
environment resulting from the transfer of the nptII and cspB genes present in maize MON 87460 to 
bacteria are unlikely, because of a highly limited potential for gene transfer. Taking into account the 
different  exposure  routes,  this  conclusion  is  mainly  based  on  the  following  assessment:  (1)  the 
integration  of  the  nptII  and  cspB  genes  through  non-homologous  recombination  is  most  unlikely 
(EFSA,  2009);  (2)  enhanced  horizontal  transfer  of  the  nptII  gene  due  to  Cre-lox-mediated 
recombination  is  unlikely;  (3)  the  stabilisation  of  the  nptII  gene  into  bacterial  cells  by  double 
homologous  recombination  of  A. tumefaciens  sequences  flanking  the  nptII  gene,  and  subsequent 
dissemination in the environment, are unlikely; and (4) the unlikely but theoretically possible transfer 
of the nptII and cspB genes in maize MON 87460 to bacteria via homology-based gene substitution 
does not raise concerns owing to the lack of an additional selective advantage that would be provided 
to the recipients in the receiving environments. The probability of horizontal gene transfer of the insert 
DNA  of  maize  MON 87460  remains  several  orders  of  magnitude  lower  than  the  gene  transfer 
efficiencies between bacteria. Therefore, its contribution to the increased prevalence of nptII genes is 
considered negligible by the EFSA GMO Panel. In summary, the analysis of horizontal gene transfer 
from  maize  MON 87460  to  bacteria  did  not  indicate  a  risk  to  human  or  animal  health  or  to  the 
environment in the context of its intended uses. 
(b) Plant-to-plant gene transfer 
Considering the intended uses of maize MON 87460 and the physical characteristics of maize seeds, 
possible pathways of gene dispersal are (accidental) grain spillage during transport and processing and 
the dispersal of pollen from occasional feral GM maize plants originating from grain spillage. 
Although GM maize plants outside cropped areas have been reported in Korea, as a result of grain 
spillage during import, transport, storage, handling and processing (Kim et al., 2006; Lee et al., 2009; 
Park et al., 2010), the survival of maize plants outside cultivation in Europe is mainly limited by a 
combination of: low competitiveness; the absence of a dormancy phase; and susceptibility to plant 
pathogens, herbivores and frost. As these general characteristics are unchanged in maize MON 87460, 
drought  tolerance  is  not  likely  to  provide  selective  advantages  outside  cultivation  in  Europe. 
Therefore, as for any other maize varieties, GM maize plants would survive in subsequent seasons 
only in warmer regions of Europe and are not likely to establish feral populations under European 
environmental conditions.  
The  extent  of  cross-pollination  with  other  maize  varieties  will  mainly  depend  on  the  scale  of 
accidental release during transport and processing and on successful establishment and subsequent 
flowering of the resulting GM maize plants. For maize, any vertical gene transfer is limited to other 
Zea  mays  plants  as  populations  of  sexually  compatible  wild  relatives  of  maize  are not  known  in 
Europe (Eastham and Sweet, 2002; OECD, 2003).  Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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The flowering  of  occasional  feral  GM  maize  plants  originating  from  accidental  release  occurring 
during transport and processing is unlikely to disperse significant amounts of GM maize pollen to 
other  maize  plants.  Field  observations  on  maize  volunteers  after  GM  maize  cultivation  in  Spain 
revealed that maize volunteers had a low vigour, rarely had cobs and produced pollen that cross-
pollinated neighbour plants only at low levels (Palaudelmàs et al., 2009). 
Pollen morphology and viability from maize MON 87460, its conventional counterpart (DM1718) and 
four non-GM maize commercial varieties were measured in pollen obtained from a field study carried 
out  under  both  well-watered  and  water-limited  conditions  in  one  location  in  the  USA  in  2007.
74 
Measures analysed included pollen viability, diameter and morphology. No statistically significant 
differences were observed between maize MON 87460 and its conventional counterpart. 
The breeding pedigree of maize MON  87460 and its conventional counterpart provided by the 
applicant confirmed that the comparator used in the pollen morphology and viability test h ad a 
comparable genetic background with maize MON  87460 (Table 2).
75  Therefore, this line can be 
regarded as a conventional counterpart. 
The EFSA GMO Panel  took into account that this application does not include cultivation of maize 
MON 87460 within the EU, so the likelihood of cross-pollination between cultivated maize and the 
occasional feral maize MON 87460 plants resulting from grain spillage is considered extremely low. 
In conclusion, maize MON 87460 can show enhanced agronomic performance characterist ics under 
water-limited  conditions  but  has  no  other  altered  survival,  multiplication  or  dissemination 
characteristics.  Therefore,  the  EFSA  GMO  Panel  considers  that  the  likelihood  of  unintended 
environmental effects as a consequence of  the spread of genes from this maize in Europe will not 
differ from that of its conventional counterpart and non-GM commercial maize varieties. 
6.1.1.3.  Interactions of the GM plant with target organisms  
Interactions of maize MON 87460 with target organisms are not considered an issue by the EFSA 
GMO Panel as there are no target organisms.  
6.1.1.4.  Interactions of the GM plant with non-target organisms 
Owing to the intended uses of maize MON 87460, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions of the GM plant with non-target organisms are not 
considered an issue by the EFSA GMO Panel.  
6.1.1.5.  Interactions with the abiotic environment and biochemical cycles 
Owing to the intended uses of maize MON 87460, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions of the GM plant with the abiotic environment and 
biogeochemical cycles are not considered an issue by the EFSA GMO Panel. 
6.1.2.  Post-market environmental monitoring 
The objectives of a monitoring plan according to Annex VII of Directive 2001/18/EC are: (1) to 
confirm that any assumption regarding the occurrence and impact of potential adverse effects of the 
GMO, or its use, in the environmental risk assessment are correct; and (2) to identify the occurrence of 
adverse effects of the GMO, or its use, on human health or the environment that were not anticipated 
in the environmental risk assessment.  
Monitoring  is  related  to  risk  management,  and  thus  a  final adoption  of  the monitoring  plan falls 
outside the mandate of EFSA. However, the EFSA GMO Panel gave its opinion on the scientific 
content of the monitoring plan provided by the applicant (EFSA, 2006b, 2011b).  
                                                       
74 Technical Dossier/Whitsel and Sammons (2008). 
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The scope of the monitoring plan provided by the applicant is in line with the intended uses of maize 
MON 87460. As the scope of the application EFSA-GMO-NL-2009-70 does not include cultivation, 
the environmental risk assessment is concerned with the accidental release into the environment of 
viable grains of maize MON 87460 during transport and processing for food and feed uses and with 
exposure through manure and faeces from animals fed maize MON 87460 grains. The environmental 
risk assessment identified no potential adverse effects to the environment. Therefore, no case-specific 
monitoring is necessary. 
The general surveillance plan proposed by the applicant includes: (1) the description of an approach 
involving operators (federations involved in maize import and processing), reporting to the applicants, 
via  a  centralised  system,  any  observed  adverse  effect(s)  of  GMOs  on  human  health  and  the 
environment; (2) a coordinating system established by EuropaBio for the collection of the information 
recorded by the various operators; and (3) the use of networks of existing surveillance systems (Lecoq 
et al., 2007; Windels et al., 2008). The applicant proposes to submit a general surveillance report on an 
annual basis and a final report at the end of the consent period.  
The EFSA GMO Panel considers that the scope of the monitoring plan provided by the applicant is in 
line with the intended uses of maize MON 87460, as the environmental risk assessment does not cover 
cultivation and identified no potential adverse environmental effects. In addition, the EFSA GMO 
Panel acknowledges the approach proposed by the applicant to put in place appropriate management 
systems to restrict environmental exposure in the case of accidental release of viable grains of maize 
MON 87460. The EFSA GMO Panel agrees with the reporting intervals proposed by the applicant in 
the general surveillance plan. 
6.2.  Conclusion 
The  scope  of  the  application  includes  import  and  processing  for  food  and  feed  uses  of  maize 
MON 87460  and  excludes  cultivation.  Considering  the  intended  uses  of  maize  MON 87460,  the 
environmental risk assessment is concerned with the accidental release into the environment of viable 
grains from maize MON 87460 during transport and processing for food and feed uses, and with the 
exposure through manure and faeces from animals fed maize MON 87460. 
In the case of accidental release into the environment of viable maize MON 87460 grains, there are no 
indications of an increased likelihood of establishment and spread of feral maize MON 87460 plants. 
Considering the intended uses of maize MON 87460 as food and feed, interactions with the biotic and 
abiotic environment are not considered to be an issue owing to the low levels of exposure. Risks 
associated with a theoretically possible horizontal transfer from maize MON 87460 nptII and cspB 
genes to bacteria have been analysed in detail, including different scenarios of integration, and did not 
raise safety concerns for the intended uses of maize MON 87460.  
The  scope  of  the  post-market  environmental  monitoring  plan  provided  by  the  applicant  and  the 
reporting intervals are in line with the intended uses of maize MON 87460 and the EFSA GMO Panel 
guidelines on the post-market environmental monitoring of GM plants (EFSA, 2006b, 2011b). In 
addition, the EFSA GMO Panel acknowledges the approach proposed by the applicant to put in place 
appropriate management systems to restrict environmental exposure in cases of accidental release of 
viable  grains  of  maize  MON 87460.  The  EFSA  GMO  Panel  agrees  with  the  reporting  intervals 
proposed by the applicant in the general surveillance plan. 
The  EFSA  GMO  Panel  recommends  that  appropriate  management  systems  should  be  in  place to 
restrict seeds of maize MON 87460 entering cultivation as this would require specific approval under 
Directive 2001/18/EC or Regulation (EC) No 1829/2003. 
CONCLUSIONS AND RECOMMENDATIONS 
The  EFSA  GMO  Panel  considers  that  the  molecular  characterisation  data  provided  for  maize 
MON 87460 are sufficient to conclude that maize MON 87460 contains a single copy of the cspB and Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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nptII expression cassettes, and lacks other sequences from the transformation vector. Bioinformatic 
analysis of the flanking sequences and the ORFs spanning the junctions created by the transformation 
did not raise safety issues. The stability of the inserted DNA was confirmed over multiple generations. 
The levels of the CspB and NPTII protein from field studies under different environmental conditions, 
including conditions in which water was limited, were assessed.  
The EFSA GMO Panel compared the composition and phenotypic and agronomic characteristics of 
maize  MON 87460  with  those  of  its  conventional  counterpart  and  non-GM  maize  commercial 
varieties  and  assessed  all  statistically  significant  differences  identified.  Based  on  the  results  of  a 
comparative analysis, the EFSA GMO Panel concludes that, besides the expression of the CspB and 
NPTII proteins, some differences were observed in the composition of forage and grain produced from 
maize  MON 87460  compared  with  its  conventional  counterpart,  when  grown  under  well-watered 
conditions. Given the magnitude of these changes and the characteristics of these endpoints, the EFSA 
GMO Panel concludes that the observed differences do not  raise safety concerns for humans and 
animals. The EFSA GMO Panel notes that under water-limited and other stressful conditions, maize 
MON 87460  can  show  enhanced  agronomic  performance  characteristics  and  some  differences  in 
chemical composition in comparison with its conventional counterpart. Given the intended trait, the 
observed differences were not unexpected and did not indicate safety concerns. 
The CspB protein is rapidly hydrolysed by pepsin and pancreatin. Bioinformatics-supported studies 
demonstrated that the CspB protein shows no homology to known toxic and allergenic proteins. There 
is no evidence that the genetic modification might significantly change the overall allergenicity of 
maize MON 87460. No indication of toxicity was found in a subchronic 90-day rat feeding study with 
diets containing grain from maize MON 87460. The results of the study on chickens for fattening 
concerning zootechnical performance support the conclusion that maize MON 87460 can be used in 
the same way as other maize sources as a feedingstuff in animal nutrition. The NPTII protein has been 
evaluated previously and did not raise safety concerns. 
The  EFSA  GMO  Panel  considers  that  maize  MON 87460  is  as  safe  and  as  nutritious  as  its 
conventional  counterpart  and  commercial  varieties,  and  concluded  that  this  maize  and  its  derived 
products are unlikely to have adverse effects on human and animal health, in the context of their 
intended uses. 
The application EFSA-GMO-NL-2009-70 is for the import and processing of maize MON 87460 for 
food and feed uses but excludes cultivation in the EU. Therefore, there is no requirement for scientific 
information on possible environmental effects associated with the cultivation of maize MON 87460. 
There are no indications of an increased likelihood of establishment and spread of feral maize plants in 
the case of accidental release into the environment of viable grains from maize MON 87460 during 
transport  and  processing.  Considering  the  intended  uses  of  maize  MON 87460  as  food  and  feed, 
interactions with the biotic and abiotic environment are not considered to be an issue owing to the low 
levels  of  exposure.  Risks  associated  with  a  theoretically  possible  horizontal  transfer  from  maize 
MON 87460 of nptII and cspB genes to bacteria have been analysed in detail, including different 
scenarios of integration, and did not raise safety concerns for the intended uses of maize MON 87460. 
The scope of the post-market environmental monitoring plan provided by the applicant is in line with 
the intended uses of maize MON 87460. Furthermore, the EFSA GMO Panel agrees with the reporting 
intervals proposed by the applicant in the general surveillance plan. 
In conclusion, the EFSA GMO Panel considers that the information available for maize MON 87460 
addresses scientific issues indicated by its risk assessment and monitoring guidelines and the scientific 
comments raised by the Member States, and that maize MON 87460, as described in this application, 
is as safe as its conventional counterpart and non-GM reference varieties with respect to potential 
effects on human and animal health and the environment, in the context of its intended uses. Scientific Opinion on genetically modified drought tolerant maize MON 87460 
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DOCUMENTATION PROVIDED TO EFSA 
1.  Letter from the Competent Authority of the Netherlands, received 29 May 2009, concerning a 
request for placing on the market of maize MON 87460 in accordance with Regulation (EC) No 
1829/2003. 
2.  Acknowledgement letter, dated 19 June 2009, from EFSA to the Competent Authority of the 
Netherlands. 
3.  Letter  from  EFSA  to  applicant,  dated  9  July  2009,  requesting  additional  information  under 
completeness check. 
4.  Letter  from  applicant  to  EFSA,  received  1  December  2009,  providing  additional  information 
under completeness check.  
5.  Letter from EFSA to applicant, dated 14 December 2009, requesting additional information under 
completeness check. 
6.  Letter from applicant to EFSA, received 8 January 2010, providing additional information under 
completeness check.  
7.  Letter from EFSA to applicant, dated 28 January 2010, delivering the “Statement of Validity” for 
application  EFSA-GMO-NL-2009-70,  maize  MON  87460  submitted  by  Monsanto  under 
Regulation (EC) No 1829/2003. 
8.  Letter  from  EFSA  to  applicant,  dated  12  May  2010,  requesting  additional  information  and 
stopping the clock. 
9.  Letter from applicant to EFSA, received 29 June 2010, providing the timeline for submission of 
response. 
10. Letter from applicant to EFSA, received 4 October 2010, providing additional information. 
11. Letter from EFSA to applicant, dated 20 December 2010, requesting additional information and 
maintaining the clock stopped. 
12. Letter from applicant to EFSA, received 10 February 2011, providing the timeline for submission 
of response. 
13. Letter from applicant to EFSA, received 18 April 2011, providing additional information. 
14. Letter  from  EFSA  to  applicant,  dated  8  July  2011,  requesting  additional  information  and 
maintaining the clock stopped. 
15. Letters from applicant to EFSA, received 7 September 2011 and 27 January 2012, providing the 
timeline for submission of response. 
16. Letter from applicant to EFSA, received 30 April 2012, providing additional information. 
17. Letter from EFSA to applicant, dated 11 September 2012, re-starting the clock. 
18. Letter  from  applicant  to  EFSA,  received  3  October  2012,  providing  additional  information 
spontaneously. 
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